component	number and frequency of mutated samples	type of mutation	genes relation	mutual exclusivity	score
[PTEN, PSMD13, TP53]	0 (0.0%)	0.78	1.00	0.87	2.65
[EGFR, PTEN, TP53]	0 (0.0%)	0.91	0.69	0.94	2.54
[PTEN, PIK3CA, TP53]	0 (0.0%)	0.81	0.67	0.97	2.44
[PTEN, PIK3CA, PIK3R1]	0 (0.0%)	0.57	1.00	0.86	2.43
[EGFR, ERBB2, TP53]	1 (0.79%)	0.52	1.00	0.90	2.42
[NF1, EGFR, TP53]	1 (0.79%)	0.71	0.70	1.00	2.41
[TP53, PTEN, PIK3R1]	0 (0.0%)	0.85	0.67	0.89	2.40
[ERBB2, PTEN, TP53]	0 (0.0%)	0.81	0.69	0.90	2.40
[PIK3C2G, PTEN, TP53]	0 (0.0%)	0.79	0.67	0.94	2.40
[PTEN, CHEK2, TP53]	1 (0.79%)	0.79	0.67	0.90	2.37
[PIK3CG, PTEN, TP53]	0 (0.0%)	0.79	0.67	0.90	2.37
[PIK3C2A, PTEN, TP53]	0 (0.0%)	0.79	0.67	0.90	2.36
[PTEN, PRKDC, TP53]	0 (0.0%)	0.79	0.67	0.87	2.33
[PTEN, TNFRSF10A, TP53]	0 (0.0%)	0.78	0.67	0.87	2.32
[NF1, PTEN, TP53]	4 (3.17%)	1.00	0.47	0.84	2.31
[CDKN2A, PTEN, TP53]	0 (0.0%)	0.80	0.67	0.84	2.31
[EGFR, PTEN, PIK3R1]	1 (0.79%)	0.68	0.69	0.92	2.29
[RB1, PTEN, TP53]	4 (3.17%)	0.89	0.67	0.71	2.27
[EGFR, PTEN, PIK3CA]	0 (0.0%)	0.63	0.69	0.90	2.23
[PIK3CG, EGFR, PTEN]	0 (0.0%)	0.62	0.69	0.84	2.16
[EGFR, PIK3C2A, PTEN]	0 (0.0%)	0.62	0.69	0.84	2.15
[RB1, CDKN2A, TP53]	0 (0.0%)	0.49	1.00	0.65	2.14
[NF1, PTEN, PIK3CA]	0 (0.0%)	0.72	0.76	0.65	2.14
[NF1, PTEN, PIK3CG]	1 (0.79%)	0.71	0.76	0.65	2.13
[EGFR, PIK3CA, TP53]	0 (0.0%)	0.52	0.67	0.94	2.12
[NF1, ERBB2, TP53]	0 (0.0%)	0.61	0.70	0.81	2.12
[EGFR, TP53, PIK3R1]	2 (1.59%)	0.56	0.67	0.89	2.11
[NF1, PTEN, PSMD13]	0 (0.0%)	0.70	0.76	0.65	2.11
[EGFR, RB1, TP53]	0 (0.0%)	0.60	0.67	0.84	2.11
[NF1, EGFR, PTEN]	0 (0.0%)	0.83	0.46	0.81	2.09
[NF1, PSMD13, TP53]	0 (0.0%)	0.58	0.70	0.81	2.09
[NF1, EGFR, PIK3CA]	0 (0.0%)	0.43	1.00	0.65	2.08
[PIK3CG, EGFR, TP53]	0 (0.0%)	0.50	0.67	0.90	2.07
[EGFR, CHEK2, TP53]	0 (0.0%)	0.50	0.67	0.90	2.07
[EGFR, PIK3C2A, TP53]	1 (0.79%)	0.50	0.67	0.90	2.07
[NF1, EGFR, PIK3CG]	0 (0.0%)	0.42	1.00	0.65	2.07
[ERBB2, PTEN, PIK3R1]	0 (0.0%)	0.57	0.69	0.79	2.06
[PIK3C2G, PTEN, PIK3R1]	0 (0.0%)	0.56	0.70	0.79	2.05
[NF1, EGFR, ERBB2]	0 (0.0%)	0.43	1.00	0.62	2.05
[PIK3C2A, PTEN, PIK3R1]	0 (0.0%)	0.56	0.70	0.79	2.05
[EGFR, PRKDC, TP53]	0 (0.0%)	0.50	0.67	0.87	2.04
[PDGFRA, PTEN, TP53]	0 (0.0%)	0.78	0.36	0.90	2.04
[PIK3CG, PTEN, PIK3R1]	0 (0.0%)	0.56	0.71	0.76	2.03
[PTEN, ITPR3, TP53]	0 (0.0%)	0.79	0.35	0.89	2.03
[EGFR, PSMD13, TP53]	0 (0.0%)	0.49	0.67	0.87	2.03
[EGFR, TNFRSF10A, TP53]	0 (0.0%)	0.49	0.67	0.87	2.03
[PDGFRA, PTEN, PIK3R1]	0 (0.0%)	0.55	0.69	0.79	2.03
[PTEN, ITGB3, PIK3R1]	0 (0.0%)	0.55	0.69	0.78	2.03
[PTEN, FGFR3, TP53]	0 (0.0%)	0.78	0.37	0.87	2.02
[EGFR, CDKN2A, TP53]	1 (0.79%)	0.51	0.67	0.84	2.02
[FGFR1, PTEN, TP53]	0 (0.0%)	0.78	0.36	0.87	2.02
[BRCA2, PTEN, TP53]	0 (0.0%)	0.78	0.36	0.87	2.01
[PTEN, FGFR3, PIK3R1]	0 (0.0%)	0.55	0.70	0.76	2.01
[PTEN, PSMD13, PIK3R1]	0 (0.0%)	0.55	0.67	0.79	2.01
[BCR, PTEN, PIK3R1]	0 (0.0%)	0.55	0.67	0.79	2.01
[FGFR1, PTEN, PIK3R1]	0 (0.0%)	0.55	0.70	0.76	2.01
[PTEN, ITGB3, TP53]	0 (0.0%)	0.79	0.36	0.86	2.01
[MET, PTEN, TP53]	0 (0.0%)	0.79	0.36	0.84	2.00
[CDKN2A, PTEN, PIK3R1]	0 (0.0%)	0.57	0.67	0.76	2.00
[MET, PTEN, PIK3R1]	0 (0.0%)	0.56	0.70	0.73	1.98
[PTEN, HLA-E, PIK3R1]	0 (0.0%)	0.55	0.67	0.76	1.98
[ERBB2, PTEN, PIK3CA]	0 (0.0%)	0.53	0.69	0.75	1.97
[PIK3CG, PTEN, PIK3CA]	0 (0.0%)	0.52	0.72	0.71	1.96
[PIK3C2A, PTEN, PIK3C2G]	0 (0.0%)	0.50	0.77	0.68	1.95
[PIK3C2A, PTEN, PIK3CA]	0 (0.0%)	0.51	0.69	0.75	1.95
[TEK, PTEN, PIK3R1]	0 (0.0%)	0.56	0.67	0.71	1.94
[PDGFRA, PTEN, PIK3CA]	0 (0.0%)	0.50	0.69	0.75	1.94
[CDKN2A, PTEN, PIK3CA]	0 (0.0%)	0.52	0.67	0.75	1.94
[PTEN, PIK3CA, ITGB3]	0 (0.0%)	0.51	0.69	0.73	1.94
[NF1, PTEN, PIK3R1]	0 (0.0%)	0.77	0.43	0.73	1.93
[MET, PTEN, PIK3CA]	0 (0.0%)	0.51	0.70	0.71	1.93
[FGFR3, PTEN, PIK3CA]	0 (0.0%)	0.50	0.70	0.71	1.92
[TEK, PTEN, PIK3CA]	0 (0.0%)	0.52	0.67	0.73	1.92
[BCR, PTEN, PIK3CA]	0 (0.0%)	0.50	0.67	0.75	1.92
[PTEN, PIK3CA, PSMD13]	0 (0.0%)	0.50	0.67	0.75	1.92
[FGFR1, PTEN, PIK3CA]	0 (0.0%)	0.50	0.70	0.71	1.92
[ERBB2, TP53, PIK3R1]	1 (0.79%)	0.45	0.67	0.79	1.91
[ERBB2, RB1, TP53]	0 (0.0%)	0.50	0.67	0.75	1.91
[PIK3CG, ERBB2, PTEN]	0 (0.0%)	0.52	0.69	0.68	1.89
[ERBB2, PIK3CA, TP53]	0 (0.0%)	0.41	0.67	0.81	1.89
[PIK3C2G, PTEN, PIK3CA]	0 (0.0%)	0.52	0.69	0.68	1.89
[PTEN, PIK3CA, HLA-E]	0 (0.0%)	0.50	0.67	0.71	1.89
[PDGFRA, EGFR, TP53]	0 (0.0%)	0.49	0.48	0.90	1.87
[PIK3CG, PIK3C2G, PTEN]	0 (0.0%)	0.50	0.68	0.68	1.87
[RB1, CHEK2, TP53]	0 (0.0%)	0.48	0.67	0.71	1.86
[RB1, PRKDC, TP53]	0 (0.0%)	0.48	0.67	0.71	1.86
[PTEN, EGFR, ERBB2]	0 (0.0%)	0.63	0.38	0.84	1.86
[EGFR, PIK3C2G, PTEN]	0 (0.0%)	0.62	0.36	0.87	1.85
[PIK3CG, PIK3C2A, PTEN]	0 (0.0%)	0.50	0.67	0.68	1.85
[PIK3CG, ERBB2, TP53]	0 (0.0%)	0.40	0.67	0.78	1.84
[PIK3CG, PTEN, FGFR3]	0 (0.0%)	0.49	0.70	0.65	1.84
[PIK3C2G, PTEN, PSMD13]	0 (0.0%)	0.49	0.67	0.68	1.84
[PIK3CG, PTEN, PSMD13]	0 (0.0%)	0.49	0.67	0.68	1.84
[NF1, EGFR, PIK3R1]	0 (0.0%)	0.48	0.67	0.70	1.84
[EGFR, PTEN, PSMD13]	0 (0.0%)	0.61	0.36	0.87	1.84
[PIK3CG, FGFR1, PTEN]	0 (0.0%)	0.49	0.70	0.65	1.84
[NF1, RB1, TP53]	2 (1.59%)	0.69	0.37	0.78	1.84
[PIK3C2A, PTEN, PSMD13]	0 (0.0%)	0.49	0.67	0.68	1.84
[EGFR, FGFR3, TP53]	0 (0.0%)	0.49	0.44	0.90	1.84
[PIK3C2A, PTEN, ITGB3]	0 (0.0%)	0.50	0.69	0.63	1.82
[EGFR, TEK, TP53]	0 (0.0%)	0.51	0.40	0.92	1.82
[EGFR, PIK3CA, PIK3R1]	0 (0.0%)	0.28	1.00	0.54	1.82
[RB1, TNFRSF10A, TP53]	0 (0.0%)	0.47	0.67	0.68	1.82
[RB1, PSMD13, TP53]	0 (0.0%)	0.47	0.67	0.68	1.82
[CDKN2A, PIK3CA, TP53]	0 (0.0%)	0.41	0.67	0.75	1.82
[NF1, PIK3CA, TP53]	0 (0.0%)	0.61	0.37	0.84	1.82
[EGFR, FGFR1, TP53]	0 (0.0%)	0.49	0.42	0.90	1.82
[CDKN2A, TP53, PIK3R1]	1 (0.79%)	0.45	0.67	0.70	1.81
[MET, EGFR, TP53]	1 (0.79%)	0.50	0.43	0.87	1.81
[NF1, PIK3CG, TP53]	0 (0.0%)	0.59	0.37	0.84	1.80
[ERBB2, CDKN2A, TP53]	0 (0.0%)	0.41	0.68	0.71	1.80
[NF1, ERBB2, PTEN]	0 (0.0%)	0.72	0.46	0.62	1.80
[PRKDC, CHEK2, TP53]	0 (0.0%)	0.39	0.67	0.75	1.80
[ERBB2, PSMD13, TP53]	0 (0.0%)	0.39	0.67	0.75	1.80
[ERBB2, TNFRSF10A, TP53]	0 (0.0%)	0.39	0.67	0.75	1.80
[EGFR, ERBB2, PIK3R1]	1 (0.79%)	0.28	1.00	0.51	1.79
[ERBB2, CHEK2, TP53]	0 (0.0%)	0.40	0.67	0.71	1.78
[NF1, CHEK2, TP53]	1 (0.79%)	0.59	0.37	0.81	1.77
[NF1, PRKDC, TP53]	0 (0.0%)	0.59	0.37	0.81	1.77
[NF1, CDKN2A, TP53]	1 (0.79%)	0.60	0.40	0.78	1.77
[CDKN2A, PRKDC, TP53]	1 (0.79%)	0.39	0.70	0.68	1.77
[CDKN2A, CHEK2, TP53]	0 (0.0%)	0.39	0.69	0.68	1.77
[NF1, PIK3C2G, PTEN]	0 (0.0%)	0.71	0.43	0.62	1.76
[NF1, PIK3C2A, PTEN]	0 (0.0%)	0.71	0.43	0.62	1.76
[NF1, EGFR, PSMD13]	0 (0.0%)	0.41	0.67	0.68	1.76
[PRKDC, TNFRSF10A, TP53]	1 (0.79%)	0.37	0.67	0.71	1.75
[PRKDC, PSMD13, TP53]	0 (0.0%)	0.37	0.67	0.71	1.75
[PSMD13, CHEK2, TP53]	0 (0.0%)	0.37	0.67	0.71	1.75
[TNFRSF10A, CHEK2, TP53]	0 (0.0%)	0.37	0.67	0.71	1.75
[EGFR, BRCA2, TP53]	1 (0.79%)	0.49	0.36	0.90	1.75
[EGFR, ITGB3, TP53]	1 (0.79%)	0.50	0.37	0.89	1.75
[ERBB2, PRKDC, TP53]	0 (0.0%)	0.40	0.67	0.68	1.75
[NF1, EGFR, PIK3C2A]	1 (0.79%)	0.42	0.67	0.65	1.73
[EGFR, ERBB2, PIK3CA]	1 (0.79%)	0.24	1.00	0.49	1.73
[NF1, TNFRSF10A, TP53]	0 (0.0%)	0.58	0.37	0.78	1.73
[DOCK1, PTEN, PIK3R1]	0 (0.0%)	0.55	0.40	0.76	1.71
[PSMD13, TNFRSF10A, TP53]	0 (0.0%)	0.36	0.67	0.68	1.71
[CDKN2A, PSMD13, TP53]	0 (0.0%)	0.38	0.67	0.65	1.70
[CDKN2A, TNFRSF10A, TP53]	2 (1.59%)	0.38	0.67	0.65	1.70
[NF1, ERBB2, PIK3CA]	0 (0.0%)	0.33	1.00	0.37	1.69
[PIK3CG, EGFR, ERBB2]	1 (0.79%)	0.23	1.00	0.46	1.69
[EGFR, FN1, TP53]	1 (0.79%)	0.49	0.35	0.84	1.68
[NF1, ERBB2, PIK3CG]	0 (0.0%)	0.32	1.00	0.37	1.68
[PDGFRA, EGFR, PTEN]	0 (0.0%)	0.61	0.19	0.87	1.68
[PTEN, FN1, PIK3R1]	0 (0.0%)	0.55	0.36	0.76	1.66
[PTEN, ITPR3, PIK3R1]	0 (0.0%)	0.55	0.35	0.75	1.65
[ERBB2, FGFR3, TP53]	0 (0.0%)	0.39	0.48	0.78	1.64
[ERBB2, TEK, TP53]	0 (0.0%)	0.40	0.44	0.79	1.64
[ERBB2, FGFR1, TP53]	0 (0.0%)	0.39	0.47	0.78	1.64
[PTEN, PIK3CA, ITPR3]	0 (0.0%)	0.51	0.35	0.76	1.63
[MET, ERBB2, TP53]	0 (0.0%)	0.40	0.48	0.75	1.62
[DOCK1, PTEN, PIK3CA]	0 (0.0%)	0.50	0.40	0.71	1.62
[EGFR, PTEN, FGFR3]	0 (0.0%)	0.61	0.16	0.84	1.61
[PDGFRA, ERBB2, TP53]	0 (0.0%)	0.39	0.44	0.78	1.61
[PTEN, PIK3CA, FN1]	0 (0.0%)	0.50	0.36	0.75	1.61
[ERBB2, PIK3C2A, PTEN]	0 (0.0%)	0.51	0.38	0.71	1.61
[PIK3C2G, PTEN, ITPR3]	0 (0.0%)	0.50	0.40	0.70	1.60
[NF1, EGFR, PDGFRA]	0 (0.0%)	0.41	0.50	0.68	1.59
[EGFR, FGFR1, PTEN]	0 (0.0%)	0.61	0.14	0.84	1.59
[ERBB2, PIK3C2G, PTEN]	0 (0.0%)	0.52	0.36	0.71	1.59
[MET, EGFR, PTEN]	0 (0.0%)	0.62	0.16	0.81	1.58
[ERBB2, PTEN, PSMD13]	0 (0.0%)	0.50	0.36	0.71	1.58
[PDGFRA, EGFR, PIK3R1]	0 (0.0%)	0.26	0.81	0.51	1.58
[NF1, EGFR, FGFR3]	0 (0.0%)	0.41	0.49	0.68	1.58
[TEK, EGFR, PTEN]	0 (0.0%)	0.63	0.09	0.86	1.57
[PIK3CG, PDGFRA, PTEN]	0 (0.0%)	0.49	0.39	0.68	1.56
[NF1, EGFR, FGFR1]	0 (0.0%)	0.41	0.47	0.68	1.56
[EGFR, PTEN, ITPR3]	0 (0.0%)	0.62	0.05	0.89	1.55
[PDGFRA, PIK3C2A, PTEN]	0 (0.0%)	0.49	0.38	0.68	1.55
[PIK3CG, PTEN, ITGB3]	0 (0.0%)	0.50	0.38	0.67	1.55
[NF1, PIK3CA, PIK3R1]	0 (0.0%)	0.37	0.67	0.51	1.55
[RB1, BRCA2, TP53]	0 (0.0%)	0.47	0.36	0.71	1.54
[PIK3C2G, PTEN, ITGB3]	0 (0.0%)	0.50	0.38	0.67	1.54
[PIK3C2A, PTEN, ITPR3]	0 (0.0%)	0.50	0.38	0.67	1.54
[PTEN, PSMD13, ITPR3]	0 (0.0%)	0.49	0.35	0.70	1.54
[EGFR, FGFR3, PIK3R1]	0 (0.0%)	0.26	0.77	0.51	1.54
[PDGFRA, PTEN, ITGB3]	0 (0.0%)	0.49	0.38	0.67	1.54
[PIK3C2A, PTEN, FGFR3]	0 (0.0%)	0.49	0.40	0.65	1.53
[PIK3CG, BCR, PTEN]	0 (0.0%)	0.49	0.36	0.68	1.53
[NF1, EGFR, MET]	1 (0.79%)	0.42	0.46	0.65	1.53
[PDGFRA, PIK3C2G, PTEN]	0 (0.0%)	0.49	0.36	0.68	1.53
[PIK3CG, TEK, PTEN]	0 (0.0%)	0.51	0.35	0.67	1.53
[ERBB2, PIK3CA, PIK3R1]	0 (0.0%)	0.18	1.00	0.35	1.53
[ERBB2, BCR, TP53]	0 (0.0%)	0.39	0.36	0.78	1.53
[EGFR, PTEN, ITGB3]	0 (0.0%)	0.62	0.09	0.83	1.53
[ERBB2, PIK3C2A, TP53]	0 (0.0%)	0.40	0.35	0.78	1.53
[FGFR1, PIK3C2A, PTEN]	0 (0.0%)	0.49	0.39	0.65	1.52
[ITGB3, PIK3CA, PIK3R1]	0 (0.0%)	0.16	1.00	0.37	1.52
[ERBB2, BRCA2, TP53]	0 (0.0%)	0.39	0.36	0.78	1.52
[ERBB2, ITGB3, TP53]	0 (0.0%)	0.39	0.37	0.76	1.52
[PIK3CG, PTEN, ITPR3]	0 (0.0%)	0.50	0.35	0.67	1.52
[PDGFRA, EGFR, PIK3CA]	0 (0.0%)	0.21	0.81	0.49	1.52
[EGFR, FGFR1, PIK3R1]	0 (0.0%)	0.26	0.75	0.51	1.52
[PIK3CG, MET, PTEN]	0 (0.0%)	0.50	0.40	0.62	1.52
[PDGFRA, PTEN, PSMD13]	0 (0.0%)	0.48	0.36	0.68	1.52
[MET, PIK3C2G, PTEN]	0 (0.0%)	0.50	0.36	0.65	1.52
[NF1, ERBB2, PIK3R1]	0 (0.0%)	0.37	0.67	0.48	1.51
[BRCA2, CHEK2, TP53]	0 (0.0%)	0.37	0.40	0.75	1.51
[PTEN, PSMD13, ITGB3]	0 (0.0%)	0.49	0.36	0.67	1.51
[MET, PIK3C2A, PTEN]	0 (0.0%)	0.50	0.39	0.62	1.51
[PIK3C2G, PTEN, FGFR3]	0 (0.0%)	0.49	0.37	0.65	1.51
[PTEN, ANK2, ITPR3]	0 (0.0%)	0.49	0.35	0.67	1.51
[FGFR1, PIK3C2G, PTEN]	0 (0.0%)	0.49	0.36	0.65	1.51
[NF1, FGFR1, TP53]	0 (0.0%)	0.58	0.08	0.84	1.51
[NF1, FGFR3, TP53]	0 (0.0%)	0.58	0.08	0.84	1.50
[MET, PTEN, PSMD13]	0 (0.0%)	0.49	0.36	0.65	1.50
[HLA-E, PIK3CA, PIK3R1]	0 (0.0%)	0.15	1.00	0.35	1.50
[PDGFRA, PIK3CA, PIK3R1]	0 (0.0%)	0.15	1.00	0.35	1.50
[BCR, PIK3CA, PIK3R1]	0 (0.0%)	0.15	1.00	0.35	1.50
[FGFR1, PIK3CA, PIK3R1]	0 (0.0%)	0.15	1.00	0.35	1.50
[FGFR3, PIK3CA, PIK3R1]	0 (0.0%)	0.15	1.00	0.35	1.50
[BRCA2, PRKDC, TP53]	0 (0.0%)	0.37	0.38	0.75	1.50
[FGFR3, PTEN, PSMD13]	0 (0.0%)	0.48	0.37	0.65	1.50
[EGFR, PTEN, FN1]	0 (0.0%)	0.61	0.04	0.84	1.49
[NF1, PDGFRA, PTEN]	0 (0.0%)	0.70	0.15	0.65	1.49
[PIK3C2A, PTEN, ROR2]	0 (0.0%)	0.49	0.35	0.65	1.49
[FGFR1, PTEN, FGFR3]	0 (0.0%)	0.48	0.40	0.62	1.49
[FGFR1, PTEN, PSMD13]	0 (0.0%)	0.48	0.36	0.65	1.49
[NF1, PTEN, FGFR3]	0 (0.0%)	0.70	0.18	0.62	1.49
[NF1, FGFR1, PTEN]	0 (0.0%)	0.70	0.18	0.62	1.49
[CDKN2A, PIK3CA, PIK3R1]	0 (0.0%)	0.17	1.00	0.32	1.49
[NF1, BRCA2, TP53]	1 (0.79%)	0.58	0.06	0.84	1.48
[NF1, PDGFRA, TP53]	0 (0.0%)	0.58	0.06	0.84	1.48
[ERBB2, EPHA7, TP53]	0 (0.0%)	0.39	0.35	0.75	1.48
[PTEN, COL1A1, ITGB3]	1 (0.79%)	0.50	0.36	0.62	1.48
[EGFR, PIK3CA, FGFR3]	0 (0.0%)	0.21	0.77	0.49	1.48
[MET, PIK3CA, PIK3R1]	0 (0.0%)	0.16	1.00	0.32	1.48
[NF1, TEK, TP53]	1 (0.79%)	0.60	0.06	0.83	1.48
[MET, EGFR, PIK3R1]	0 (0.0%)	0.27	0.77	0.44	1.48
[NF1, BCR, TP53]	0 (0.0%)	0.58	0.06	0.84	1.48
[NF1, EGFR, TEK]	0 (0.0%)	0.42	0.42	0.63	1.48
[FGFR1, PTEN, BCL11A]	1 (0.79%)	0.49	0.36	0.62	1.47
[TEK, PIK3CA, PIK3R1]	0 (0.0%)	0.17	1.00	0.30	1.47
[EGFR, TEK, PIK3CA]	0 (0.0%)	0.23	0.73	0.51	1.47
[NF1, BCR, PTEN]	0 (0.0%)	0.70	0.12	0.65	1.47
[NF1, MET, TP53]	1 (0.79%)	0.59	0.07	0.81	1.47
[EGFR, TEK, PIK3R1]	0 (0.0%)	0.27	0.73	0.46	1.46
[EGFR, FGFR1, PIK3CA]	0 (0.0%)	0.21	0.75	0.49	1.46
[NF1, CDKN2A, PTEN]	0 (0.0%)	0.72	0.12	0.62	1.46
[NF1, PTEN, ITPR3]	0 (0.0%)	0.70	0.12	0.63	1.46
[PIK3CG, EGFR, PIK3R1]	0 (0.0%)	0.27	0.71	0.48	1.46
[ERBB2, FN1, TP53]	0 (0.0%)	0.39	0.35	0.71	1.45
[EGFR, ITGB3, PIK3R1]	0 (0.0%)	0.26	0.70	0.49	1.45
[NF1, MET, PTEN]	0 (0.0%)	0.71	0.16	0.59	1.45
[MET, EGFR, PIK3CA]	0 (0.0%)	0.22	0.77	0.46	1.45
[PTEN, FN1, ITGB3]	0 (0.0%)	0.49	0.36	0.60	1.45
[NF1, EGFR, ITGB3]	1 (0.79%)	0.41	0.37	0.67	1.45
[CDKN2A, TEK, TP53]	0 (0.0%)	0.40	0.35	0.70	1.45
[PIK3CG, EGFR, PIK3CA]	1 (0.79%)	0.23	0.72	0.49	1.44
[EGFR, PIK3C2A, PIK3R1]	0 (0.0%)	0.27	0.70	0.48	1.44
[NF1, EGFR, BCR]	0 (0.0%)	0.41	0.35	0.68	1.44
[COL6A2, PTEN, ITGB3]	1 (0.79%)	0.49	0.36	0.59	1.44
[NF1, EGFR, CDKN2A]	1 (0.79%)	0.43	0.36	0.65	1.44
[PIK3CG, EGFR, FGFR3]	0 (0.0%)	0.20	0.77	0.46	1.44
[NF1, TEK, PTEN]	1 (0.79%)	0.71	0.12	0.60	1.44
[PDGFRA, ITGB3, PIK3R1]	0 (0.0%)	0.13	1.00	0.30	1.43
[BRCA2, PSMD13, TP53]	0 (0.0%)	0.36	0.36	0.71	1.43
[BRCA2, TNFRSF10A, TP53]	0 (0.0%)	0.36	0.36	0.71	1.43
[NF1, PTEN, ITGB3]	0 (0.0%)	0.70	0.13	0.60	1.43
[EGFR, HLA-E, PIK3R1]	0 (0.0%)	0.26	0.67	0.51	1.43
[EGFR, BCR, PIK3R1]	0 (0.0%)	0.26	0.67	0.51	1.43
[MSH6, PRKDC, TP53]	1 (0.79%)	0.38	0.35	0.70	1.43
[CDKN2A, BRCA2, TP53]	1 (0.79%)	0.38	0.36	0.68	1.42
[PTEN, TNC, ITGB3]	0 (0.0%)	0.49	0.36	0.57	1.42
[PIK3CG, EGFR, FGFR1]	0 (0.0%)	0.20	0.75	0.46	1.42
[CDKN2A, FGFR1, TP53]	0 (0.0%)	0.38	0.35	0.68	1.42
[CDKN2A, FGFR3, TP53]	0 (0.0%)	0.38	0.35	0.68	1.42
[NF1, FGFR1, PIK3CA]	0 (0.0%)	0.30	0.71	0.40	1.41
[NF1, FGFR3, PIK3CA]	0 (0.0%)	0.30	0.71	0.40	1.41
[FGFR1, FGFR3, PIK3R1]	0 (0.0%)	0.13	1.00	0.29	1.41
[NF1, EGFR, FN1]	1 (0.79%)	0.41	0.35	0.65	1.41
[NF1, PIK3CA, PIK3CG]	0 (0.0%)	0.32	0.72	0.37	1.41
[MET, ERBB2, PTEN]	0 (0.0%)	0.51	0.20	0.68	1.40
[NF1, FGFR1, PIK3CG]	0 (0.0%)	0.29	0.71	0.40	1.40
[NF1, FGFR3, PIK3CG]	0 (0.0%)	0.29	0.71	0.40	1.40
[EGFR, PIK3CA, ITGB3]	0 (0.0%)	0.22	0.70	0.48	1.40
[NF1, PDGFRA, PIK3CA]	0 (0.0%)	0.30	0.69	0.40	1.39
[ERBB2, PTEN, FGFR3]	0 (0.0%)	0.50	0.20	0.68	1.39
[EGFR, CDKN2A, PIK3R1]	0 (0.0%)	0.28	0.67	0.44	1.39
[NF1, BCR, PIK3CA]	0 (0.0%)	0.30	0.69	0.40	1.39
[ERBB2, FGFR1, PTEN]	0 (0.0%)	0.50	0.19	0.68	1.38
[NF1, CDKN2A, PIK3CA]	0 (0.0%)	0.32	0.69	0.37	1.38
[PDGFRA, ERBB2, PTEN]	0 (0.0%)	0.50	0.16	0.71	1.38
[NF1, MET, PIK3CA]	0 (0.0%)	0.31	0.70	0.37	1.37
[EGFR, PIK3C2A, PIK3CA]	0 (0.0%)	0.22	0.69	0.46	1.37
[EGFR, HLA-E, PIK3CA]	0 (0.0%)	0.21	0.67	0.49	1.37
[EGFR, BCR, PIK3CA]	0 (0.0%)	0.21	0.67	0.49	1.37
[NF1, ERBB2, PSMD13]	0 (0.0%)	0.30	0.67	0.40	1.37
[NF1, PIK3CA, PSMD13]	0 (0.0%)	0.30	0.67	0.40	1.37
[EGFR, CDKN2A, PIK3CA]	0 (0.0%)	0.23	0.67	0.46	1.36
[NF1, PIK3CA, ITGB3]	0 (0.0%)	0.31	0.67	0.38	1.36
[NF1, TEK, PIK3CA]	0 (0.0%)	0.32	0.69	0.35	1.36
[NF1, PSMD13, PIK3CG]	0 (0.0%)	0.29	0.67	0.40	1.35
[TEK, ERBB2, PTEN]	0 (0.0%)	0.52	0.13	0.70	1.35
[PDGFRA, PTEN, FGFR3]	0 (0.0%)	0.48	0.21	0.65	1.34
[EGFR, PIK3C2A, ERBB2]	0 (0.0%)	0.22	0.68	0.43	1.34
[NF1, HLA-E, PIK3CA]	0 (0.0%)	0.30	0.67	0.37	1.34
[EGFR, PIK3C2A, ITGB3]	1 (0.79%)	0.20	0.70	0.41	1.32
[PDGFRA, PIK3CA, ITGB3]	0 (0.0%)	0.09	1.00	0.22	1.31
[PDGFRA, MET, PTEN]	0 (0.0%)	0.49	0.17	0.65	1.31
[PIK3CG, EGFR, PIK3C2A]	0 (0.0%)	0.21	0.67	0.43	1.31
[MET, PTEN, FGFR3]	0 (0.0%)	0.49	0.20	0.62	1.31
[RB1, CDKN2A, PIK3R1]	0 (0.0%)	0.26	0.67	0.38	1.30
[TEK, FGFR1, PTEN]	0 (0.0%)	0.50	0.17	0.63	1.30
[MET, FGFR1, PTEN]	1 (0.79%)	0.49	0.19	0.62	1.30
[ERBB2, PTEN, ITGB3]	0 (0.0%)	0.51	0.09	0.70	1.30
[TEK, PTEN, FGFR3]	0 (0.0%)	0.50	0.17	0.63	1.30
[PDGFRA, TEK, PTEN]	0 (0.0%)	0.50	0.13	0.67	1.29
[MET, TEK, PTEN]	0 (0.0%)	0.50	0.15	0.63	1.29
[FGFR1, PIK3CA, FGFR3]	0 (0.0%)	0.08	1.00	0.21	1.29
[ERBB2, PTEN, ITPR3]	0 (0.0%)	0.51	0.05	0.73	1.29
[ERBB2, FGFR3, PIK3R1]	0 (0.0%)	0.15	0.81	0.32	1.28
[ERBB2, CDKN2A, PTEN]	0 (0.0%)	0.52	0.04	0.71	1.28
[ERBB2, FGFR1, PIK3R1]	0 (0.0%)	0.15	0.81	0.32	1.28
[ERBB2, BCR, PTEN]	0 (0.0%)	0.50	0.06	0.71	1.27
[ERBB2, PTEN, FN1]	0 (0.0%)	0.50	0.05	0.71	1.27
[PDGFRA, FGFR1, PTEN]	0 (0.0%)	0.48	0.17	0.62	1.26
[MET, ERBB2, PIK3R1]	0 (0.0%)	0.16	0.82	0.29	1.26
[PDGFRA, EGFR, ERBB2]	0 (0.0%)	0.21	0.59	0.46	1.26
[ERBB2, PTEN, EPHA7]	0 (0.0%)	0.50	0.04	0.71	1.26
[EGFR, ERBB2, FGFR3]	0 (0.0%)	0.21	0.59	0.46	1.26
[PDGFRA, ERBB2, PIK3R1]	0 (0.0%)	0.15	0.78	0.32	1.25
[PIK3CG, FGFR1, FGFR3]	0 (0.0%)	0.07	1.00	0.17	1.25
[PDGFRA, FGFR3, PIK3R1]	0 (0.0%)	0.13	0.83	0.29	1.24
[MET, EGFR, ERBB2]	0 (0.0%)	0.22	0.58	0.43	1.24
[EGFR, FGFR1, ERBB2]	0 (0.0%)	0.21	0.56	0.46	1.23
[NF1, FGFR1, PIK3R1]	0 (0.0%)	0.35	0.38	0.51	1.23
[NF1, FGFR3, PIK3R1]	0 (0.0%)	0.35	0.38	0.51	1.23
[PDGFRA, PTEN, ITPR3]	0 (0.0%)	0.49	0.04	0.70	1.23
[NF1, ERBB2, FGFR3]	0 (0.0%)	0.30	0.53	0.40	1.23
[PTEN, FGFR3, ITPR3]	0 (0.0%)	0.49	0.07	0.67	1.23
[FGFR1, PTEN, ITPR3]	0 (0.0%)	0.49	0.07	0.67	1.22
[CYP27B1, PTEN, ITPR3]	0 (0.0%)	0.49	0.04	0.70	1.22
[NF1, ERBB2, FGFR1]	0 (0.0%)	0.30	0.52	0.40	1.22
[FGFR1, PTEN, ITGB3]	1 (0.79%)	0.49	0.09	0.63	1.21
[RB1, CDKN2A, PIK3CA]	0 (0.0%)	0.21	0.67	0.33	1.21
[NF1, PIK3CG, PIK3R1]	0 (0.0%)	0.36	0.38	0.48	1.21
[NF1, PDGFRA, PIK3R1]	0 (0.0%)	0.35	0.36	0.51	1.21
[ERBB2, TEK, PIK3R1]	0 (0.0%)	0.17	0.77	0.27	1.21
[PTEN, ITPR3, ITGB3]	0 (0.0%)	0.49	0.07	0.65	1.21
[TEK, EGFR, ERBB2]	0 (0.0%)	0.23	0.50	0.48	1.21
[PDGFRA, BCR, PTEN]	0 (0.0%)	0.48	0.05	0.68	1.21
[TEK, PTEN, ITGB3]	0 (0.0%)	0.50	0.06	0.65	1.21
[NF1, BCR, PIK3R1]	0 (0.0%)	0.35	0.35	0.51	1.21
[MET, BCR, PTEN]	0 (0.0%)	0.49	0.06	0.65	1.20
[CDKN2A, PTEN, FGFR3]	0 (0.0%)	0.50	0.05	0.65	1.20
[CDKN2A, FGFR1, PTEN]	0 (0.0%)	0.50	0.05	0.65	1.20
[MET, PTEN, ITGB3]	1 (0.79%)	0.50	0.10	0.60	1.20
[ERBB2, ITGB3, PIK3R1]	0 (0.0%)	0.16	0.70	0.33	1.19
[MET, FGFR3, PIK3R1]	0 (0.0%)	0.14	0.80	0.25	1.19
[NF1, ERBB2, MET]	0 (0.0%)	0.31	0.51	0.37	1.19
[BCR, PTEN, FGFR3]	0 (0.0%)	0.48	0.06	0.65	1.19
[FGFR1, TEK, PIK3R1]	0 (0.0%)	0.14	0.81	0.24	1.19
[FGFR1, BCR, PTEN]	0 (0.0%)	0.48	0.06	0.65	1.19
[MET, PTEN, EPHA7]	0 (0.0%)	0.49	0.05	0.65	1.19
[PTEN, FGFR3, ITGB3]	0 (0.0%)	0.49	0.09	0.60	1.18
[MET, PTEN, ITPR3]	0 (0.0%)	0.50	0.05	0.63	1.18
[TEK, FGFR3, PIK3R1]	0 (0.0%)	0.14	0.80	0.24	1.18
[EGFR, FGFR1, FGFR3]	0 (0.0%)	0.19	0.53	0.46	1.18
[PDGFRA, MET, PIK3R1]	0 (0.0%)	0.14	0.79	0.25	1.18
[EGFR, PIK3C2G, PIK3R1]	0 (0.0%)	0.27	0.37	0.54	1.17
[MET, ERBB2, PIK3CA]	0 (0.0%)	0.12	0.82	0.24	1.17
[PIK3CG, EGFR, PDGFRA]	0 (0.0%)	0.20	0.51	0.46	1.17
[NF1, ERBB2, PDGFRA]	0 (0.0%)	0.30	0.47	0.40	1.17
[NF1, CDKN2A, PIK3R1]	0 (0.0%)	0.37	0.36	0.44	1.17
[ERBB2, BCR, PIK3R1]	0 (0.0%)	0.15	0.70	0.32	1.17
[BCR, PTEN, ITGB3]	0 (0.0%)	0.49	0.04	0.63	1.17
[PIK3CG, ERBB2, PIK3R1]	0 (0.0%)	0.17	0.71	0.29	1.16
[NF1, MET, PIK3R1]	0 (0.0%)	0.36	0.36	0.44	1.16
[ERBB2, PIK3CA, FGFR3]	0 (0.0%)	0.11	0.81	0.24	1.16
[NF1, RB1, CDKN2A]	0 (0.0%)	0.41	0.36	0.40	1.16
[PDGFRA, FGFR1, PIK3R1]	0 (0.0%)	0.13	0.78	0.25	1.16
[MET, FGFR1, PIK3R1]	0 (0.0%)	0.14	0.80	0.22	1.16
[PDGFRA, TEK, PIK3R1]	0 (0.0%)	0.14	0.78	0.24	1.16
[ERBB2, TEK, PIK3CA]	0 (0.0%)	0.13	0.77	0.25	1.15
[ERBB2, FGFR1, PIK3CA]	0 (0.0%)	0.11	0.81	0.24	1.15
[PDGFRA, EGFR, ITGB3]	0 (0.0%)	0.19	0.51	0.44	1.15
[MET, TEK, PIK3R1]	0 (0.0%)	0.15	0.79	0.21	1.15
[NF1, TEK, PIK3R1]	1 (0.79%)	0.36	0.35	0.43	1.14
[ERBB2, CDKN2A, PIK3R1]	0 (0.0%)	0.17	0.68	0.29	1.14
[ERBB2, HLA-E, PIK3R1]	0 (0.0%)	0.15	0.67	0.32	1.14
[PIK3CG, FGFR3, PIK3R1]	0 (0.0%)	0.14	0.71	0.29	1.14
[PIK3CG, FGFR1, PIK3R1]	0 (0.0%)	0.14	0.71	0.29	1.14
[EGFR, DOCK1, PIK3R1]	0 (0.0%)	0.26	0.40	0.48	1.13
[MET, PTEN, FN1]	0 (0.0%)	0.49	0.06	0.59	1.13
[FGFR1, TEK, PIK3CA]	0 (0.0%)	0.10	0.81	0.22	1.13
[NF1, ERBB2, TEK]	0 (0.0%)	0.32	0.46	0.35	1.13
[COL1A1, FN1, ITGB3]	1 (0.79%)	0.08	1.00	0.05	1.13
[PDGFRA, EGFR, PIK3C2A]	0 (0.0%)	0.20	0.50	0.43	1.13
[PDGFRA, ERBB2, PIK3CA]	0 (0.0%)	0.11	0.78	0.24	1.12
[MET, PTEN, DOCK1]	1 (0.79%)	0.49	0.05	0.59	1.12
[FGFR3, TEK, PIK3CA]	0 (0.0%)	0.10	0.80	0.22	1.12
[MET, TEK, PIK3CA]	0 (0.0%)	0.11	0.79	0.22	1.12
[COL6A2, FN1, ITGB3]	1 (0.79%)	0.07	1.00	0.05	1.12
[PIK3CG, ERBB2, FGFR3]	0 (0.0%)	0.10	0.81	0.21	1.12
[PDGFRA, FGFR3, PIK3CA]	0 (0.0%)	0.08	0.83	0.21	1.12
[PIK3C2A, ITGB3, PIK3R1]	0 (0.0%)	0.14	0.70	0.27	1.11
[MSH6, BRCA2, TP53]	1 (0.79%)	0.37	0.05	0.70	1.11
[PIK3CG, EGFR, TEK]	0 (0.0%)	0.22	0.42	0.48	1.11
[PIK3CG, ERBB2, FGFR1]	0 (0.0%)	0.10	0.81	0.21	1.11
[FGFR1, BCR, PIK3R1]	0 (0.0%)	0.13	0.69	0.29	1.11
[PDGFRA, BCR, PIK3R1]	0 (0.0%)	0.13	0.69	0.29	1.11
[BCR, FGFR3, PIK3R1]	0 (0.0%)	0.13	0.69	0.29	1.11
[FGFR1, ITGB3, PIK3R1]	0 (0.0%)	0.13	0.70	0.27	1.11
[EGFR, PIK3C2A, PIK3C2G]	0 (0.0%)	0.21	0.43	0.46	1.10
[ITGB3, FGFR3, PIK3R1]	0 (0.0%)	0.13	0.70	0.27	1.10
[MET, FGFR3, PIK3CA]	0 (0.0%)	0.09	0.80	0.21	1.10
[HLA-E, ITGB3, PIK3R1]	0 (0.0%)	0.13	0.67	0.30	1.10
[NF1, FGFR1, FGFR3]	0 (0.0%)	0.28	0.43	0.40	1.10
[TEK, ITGB3, PIK3R1]	0 (0.0%)	0.15	0.70	0.25	1.10
[PDGFRA, TEK, PIK3CA]	0 (0.0%)	0.10	0.78	0.22	1.10
[EGFR, PIK3C2A, FGFR3]	0 (0.0%)	0.20	0.47	0.43	1.10
[MET, BCR, PIK3R1]	0 (0.0%)	0.14	0.70	0.25	1.09
[CDKN2A, FGFR1, PIK3R1]	0 (0.0%)	0.15	0.69	0.25	1.09
[BCR, ITGB3, PIK3R1]	0 (0.0%)	0.13	0.68	0.27	1.09
[PIK3CG, ERBB2, PIK3CA]	1 (0.79%)	0.12	0.72	0.24	1.09
[CDKN2A, FGFR3, PIK3R1]	0 (0.0%)	0.15	0.69	0.25	1.09
[PDGFRA, MET, PIK3CA]	0 (0.0%)	0.09	0.79	0.21	1.09
[NF1, ERBB2, BCR]	0 (0.0%)	0.30	0.38	0.40	1.08
[EGFR, FGFR1, BCL11A]	0 (0.0%)	0.20	0.42	0.46	1.08
[FGFR1, HLA-E, PIK3R1]	0 (0.0%)	0.13	0.67	0.29	1.08
[HLA-E, FGFR3, PIK3R1]	0 (0.0%)	0.13	0.67	0.29	1.08
[PDGFRA, HLA-E, PIK3R1]	0 (0.0%)	0.13	0.67	0.29	1.08
[BCR, HLA-E, PIK3R1]	0 (0.0%)	0.13	0.67	0.29	1.08
[NF1, PDGFRA, PIK3CG]	0 (0.0%)	0.29	0.39	0.40	1.08
[BCR, TEK, PIK3R1]	0 (0.0%)	0.14	0.70	0.24	1.08
[EGFR, FN1, PIK3R1]	0 (0.0%)	0.26	0.37	0.44	1.08
[EGFR, DOCK1, PIK3CA]	0 (0.0%)	0.21	0.40	0.46	1.07
[PIK3CG, EGFR, MET]	0 (0.0%)	0.21	0.47	0.40	1.07
[ERBB2, PIK3CA, ITGB3]	0 (0.0%)	0.12	0.70	0.25	1.07
[ITGB3, COL1A1, PIK3R1]	0 (0.0%)	0.15	0.67	0.25	1.07
[FGFR1, EGFR, PIK3C2A]	0 (0.0%)	0.20	0.44	0.43	1.07
[NF1, DOCK1, PIK3CA]	0 (0.0%)	0.30	0.40	0.37	1.07
[MET, FGFR1, PIK3CA]	0 (0.0%)	0.09	0.80	0.17	1.07
[CDKN2A, HLA-E, PIK3R1]	0 (0.0%)	0.15	0.67	0.25	1.07
[PDGFRA, CDKN2A, PIK3R1]	0 (0.0%)	0.15	0.67	0.25	1.07
[MET, EGFR, PIK3C2A]	1 (0.79%)	0.21	0.46	0.40	1.07
[EGFR, TEK, FN1]	0 (0.0%)	0.20	0.42	0.44	1.06
[NF1, BCR, PIK3CG]	0 (0.0%)	0.29	0.38	0.40	1.06
[EGFR, ERBB2, ITGB3]	0 (0.0%)	0.22	0.40	0.44	1.06
[NF1, ERBB2, CDKN2A]	0 (0.0%)	0.32	0.37	0.37	1.06
[PDGFRA, EGFR, FGFR3]	0 (0.0%)	0.19	0.41	0.46	1.06
[NF1, ERBB2, ITGB3]	0 (0.0%)	0.31	0.37	0.38	1.06
[MET, HLA-E, PIK3R1]	0 (0.0%)	0.14	0.67	0.25	1.06
[PIK3CG, EGFR, PIK3C2G]	0 (0.0%)	0.21	0.35	0.49	1.06
[MET, ITGB3, PIK3R1]	0 (0.0%)	0.14	0.71	0.21	1.06
[EGFR, PIK3C2A, TEK]	0 (0.0%)	0.21	0.40	0.44	1.06
[NF1, FGFR1, PSMD13]	0 (0.0%)	0.28	0.38	0.40	1.05
[NF1, FGFR3, PSMD13]	0 (0.0%)	0.28	0.38	0.40	1.05
[CDKN2A, TEK, PIK3R1]	0 (0.0%)	0.16	0.68	0.21	1.05
[ERBB2, CDKN2A, PIK3CA]	0 (0.0%)	0.13	0.68	0.24	1.05
[NF1, PIK3C2G, PIK3CG]	0 (0.0%)	0.30	0.35	0.40	1.05
[NF1, ERBB2, EPHA7]	0 (0.0%)	0.30	0.35	0.40	1.05
[EGFR, PIK3CA, FN1]	0 (0.0%)	0.21	0.37	0.46	1.05
[TEK, HLA-E, PIK3R1]	0 (0.0%)	0.14	0.67	0.24	1.05
[ERBB2, BCR, PIK3CA]	0 (0.0%)	0.11	0.70	0.24	1.04
[TEK, PIK3CA, ITGB3]	0 (0.0%)	0.11	0.70	0.24	1.04
[EGFR, PIK3C2G, PIK3CA]	0 (0.0%)	0.23	0.35	0.46	1.04
[PDGFRA, FGFR1, PIK3CA]	0 (0.0%)	0.08	0.78	0.17	1.04
[TEK, FN1, PIK3R1]	0 (0.0%)	0.14	0.69	0.21	1.04
[ITGB3, TNC, PIK3R1]	0 (0.0%)	0.13	0.67	0.24	1.04
[PIK3CG, EGFR, ITGB3]	0 (0.0%)	0.21	0.39	0.44	1.04
[EGFR, BCR, ERBB2]	0 (0.0%)	0.21	0.36	0.46	1.04
[CDKN2A, BCR, PIK3R1]	0 (0.0%)	0.15	0.67	0.22	1.03
[NF1, PIK3C2G, PIK3CA]	1 (0.79%)	0.32	0.35	0.37	1.03
[NF1, PIK3C2A, PIK3CA]	0 (0.0%)	0.31	0.36	0.37	1.03
[NF1, PDGFRA, PSMD13]	0 (0.0%)	0.28	0.36	0.40	1.03
[NF1, PIK3CG, ITGB3]	0 (0.0%)	0.30	0.35	0.38	1.03
[NF1, ERBB2, PIK3C2A]	0 (0.0%)	0.31	0.35	0.37	1.03
[NF1, MET, PIK3CG]	0 (0.0%)	0.30	0.40	0.33	1.03
[NF1, TEK, PIK3CG]	0 (0.0%)	0.31	0.37	0.35	1.03
[PIK3CG, FGFR3, PIK3CA]	0 (0.0%)	0.10	0.72	0.21	1.03
[PIK3CG, FGFR1, PIK3CA]	0 (0.0%)	0.10	0.72	0.21	1.03
[COL6A2, ITGB3, PIK3R1]	0 (0.0%)	0.14	0.67	0.22	1.03
[FGFR1, BCL11A, PIK3R1]	0 (0.0%)	0.14	0.67	0.22	1.03
[ITGB3, FN1, PIK3R1]	0 (0.0%)	0.13	0.69	0.21	1.03
[NF1, BCR, PSMD13]	0 (0.0%)	0.28	0.35	0.40	1.03
[CDKN2A, TEK, PIK3CA]	0 (0.0%)	0.12	0.68	0.22	1.03
[COL6A2, COL1A1, FN1]	1 (0.79%)	0.08	0.87	0.08	1.03
[CDKN2A, ITGB3, PIK3R1]	0 (0.0%)	0.15	0.67	0.21	1.03
[NF1, PIK3CA, FN1]	0 (0.0%)	0.30	0.36	0.37	1.02
[NF1, PDGFRA, ITGB3]	0 (0.0%)	0.28	0.36	0.38	1.02
[NF1, ERBB2, FN1]	0 (0.0%)	0.30	0.35	0.37	1.02
[NF1, CDKN2A, PSMD13]	0 (0.0%)	0.30	0.36	0.37	1.02
[BCR, TEK, PIK3CA]	0 (0.0%)	0.10	0.70	0.22	1.02
[PIK3CG, EGFR, BCR]	0 (0.0%)	0.20	0.36	0.46	1.02
[COL6A2, COL1A1, ITGB3]	2 (1.59%)	0.09	0.87	0.06	1.02
[EGFR, ERBB2, FN1]	0 (0.0%)	0.21	0.37	0.43	1.02
[ERBB2, HLA-E, PIK3CA]	0 (0.0%)	0.11	0.67	0.24	1.02
[NF1, MET, PSMD13]	0 (0.0%)	0.29	0.36	0.37	1.01
[MET, CDKN2A, PIK3R1]	1 (0.79%)	0.16	0.67	0.19	1.01
[EGFR, CDKN2A, ERBB2]	0 (0.0%)	0.23	0.35	0.43	1.01
[TEK, PIK3CA, FN1]	0 (0.0%)	0.10	0.69	0.22	1.01
[NF1, FGFR1, BCL11A]	0 (0.0%)	0.29	0.38	0.33	1.00
[NF1, CDKN2A, PIK3CG]	0 (0.0%)	0.31	0.36	0.33	1.00
[MET, BCR, PIK3CA]	0 (0.0%)	0.09	0.70	0.21	1.00
[PDGFRA, EGFR, TEK]	0 (0.0%)	0.20	0.32	0.48	1.00
[CDKN2A, FGFR1, PIK3CA]	0 (0.0%)	0.10	0.69	0.21	1.00
[CDKN2A, PIK3CA, FGFR3]	0 (0.0%)	0.10	0.69	0.21	1.00
[NF1, TEK, PSMD13]	0 (0.0%)	0.29	0.35	0.35	1.00
[EGFR, ERBB2, EPHA7]	0 (0.0%)	0.21	0.35	0.43	0.99
[PDGFRA, EGFR, MET]	0 (0.0%)	0.20	0.37	0.43	0.99
[TEK, PIK3CA, HLA-E]	0 (0.0%)	0.10	0.67	0.22	0.99
[FGFR1, BCR, PIK3CA]	0 (0.0%)	0.08	0.69	0.21	0.99
[PDGFRA, BCR, PIK3CA]	0 (0.0%)	0.08	0.69	0.21	0.98
[FGFR3, BCR, PIK3CA]	0 (0.0%)	0.08	0.69	0.21	0.98
[EGFR, TEK, FGFR3]	0 (0.0%)	0.20	0.30	0.48	0.98
[FGFR1, PIK3CA, ITGB3]	0 (0.0%)	0.09	0.70	0.19	0.98
[FGFR3, PIK3CA, ITGB3]	0 (0.0%)	0.09	0.70	0.19	0.98
[PIK3C2A, PIK3CA, ITGB3]	0 (0.0%)	0.10	0.69	0.19	0.98
[HLA-E, PIK3CA, ITGB3]	0 (0.0%)	0.09	0.67	0.22	0.98
[PDGFRA, CDKN2A, PIK3CA]	0 (0.0%)	0.10	0.67	0.21	0.98
[CDKN2A, HLA-E, PIK3CA]	0 (0.0%)	0.10	0.67	0.21	0.98
[EGFR, PIK3C2A, ITPR3]	0 (0.0%)	0.20	0.36	0.41	0.97
[EGFR, COL1A1, ITGB3]	0 (0.0%)	0.21	0.37	0.40	0.97
[EGFR, FGFR1, TEK]	0 (0.0%)	0.20	0.29	0.48	0.97
[FGFR1, BCL11A, PIK3CA]	0 (0.0%)	0.10	0.67	0.21	0.97
[MET, EGFR, FGFR3]	0 (0.0%)	0.20	0.34	0.43	0.97
[DOCK1, PIK3CA, PIK3R1]	0 (0.0%)	0.15	0.47	0.35	0.97
[EGFR, COL1A1, FN1]	0 (0.0%)	0.20	0.35	0.41	0.97
[MET, HLA-E, PIK3CA]	0 (0.0%)	0.09	0.67	0.21	0.97
[MET, PIK3CA, ITGB3]	0 (0.0%)	0.10	0.71	0.16	0.97
[BCR, PIK3CA, ITGB3]	0 (0.0%)	0.09	0.68	0.19	0.96
[NF1, TEK, FN1]	0 (0.0%)	0.29	0.35	0.32	0.96
[PDGFRA, EGFR, FGFR1]	0 (0.0%)	0.19	0.35	0.43	0.96
[EGFR, COL6A2, ITGB3]	0 (0.0%)	0.20	0.37	0.40	0.96
[EGFR, FN1, ITGB3]	1 (0.79%)	0.19	0.38	0.38	0.96
[EGFR, COL6A2, FN1]	0 (0.0%)	0.19	0.35	0.41	0.96
[FGFR1, HLA-E, PIK3CA]	0 (0.0%)	0.08	0.67	0.21	0.96
[BCR, HLA-E, PIK3CA]	0 (0.0%)	0.08	0.67	0.21	0.96
[FGFR3, HLA-E, PIK3CA]	0 (0.0%)	0.08	0.67	0.21	0.96
[PDGFRA, HLA-E, PIK3CA]	0 (0.0%)	0.08	0.67	0.21	0.96
[PIK3CG, EGFR, FN1]	0 (0.0%)	0.20	0.35	0.40	0.95
[COL1A1, PIK3CA, ITGB3]	0 (0.0%)	0.11	0.67	0.17	0.95
[EGFR, PIK3C2A, FN1]	1 (0.79%)	0.20	0.35	0.40	0.95
[CDKN2A, BCR, PIK3CA]	0 (0.0%)	0.10	0.67	0.17	0.95
[MET, EGFR, TEK]	0 (0.0%)	0.21	0.29	0.44	0.94
[EGFR, TNC, ITGB3]	1 (0.79%)	0.19	0.37	0.38	0.94
[COL6A2, PIK3CA, ITGB3]	0 (0.0%)	0.10	0.67	0.17	0.94
[PIK3CA, FN1, ITGB3]	0 (0.0%)	0.09	0.69	0.16	0.94
[CDKN2A, PIK3CA, ITGB3]	0 (0.0%)	0.11	0.67	0.16	0.94
[MET, CDKN2A, PIK3CA]	0 (0.0%)	0.11	0.67	0.14	0.92
[PIK3CG, PIK3CA, PIK3R1]	0 (0.0%)	0.17	0.44	0.32	0.92
[EGFR, PIK3C2A, ROR2]	1 (0.79%)	0.20	0.35	0.37	0.92
[PIK3CA, TNC, ITGB3]	0 (0.0%)	0.09	0.67	0.16	0.92
[MET, EGFR, FGFR1]	0 (0.0%)	0.20	0.32	0.40	0.91
[ERBB2, FGFR1, FGFR3]	0 (0.0%)	0.08	0.62	0.21	0.91
[NF1, PDGFRA, FGFR3]	0 (0.0%)	0.28	0.23	0.40	0.90
[PIK3C2A, PIK3CA, PIK3R1]	0 (0.0%)	0.16	0.39	0.35	0.90
[TEK, COL1A1, FN1]	0 (0.0%)	0.09	0.67	0.14	0.90
[ERBB2, RB1, CDKN2A]	0 (0.0%)	0.21	0.35	0.33	0.90
[PIK3CG, FGFR1, BCL11A]	0 (0.0%)	0.08	0.67	0.14	0.89
[COL1A1, TNC, ITGB3]	1 (0.79%)	0.08	0.76	0.05	0.89
[PDGFRA, PIK3C2A, ITGB3]	0 (0.0%)	0.07	0.69	0.13	0.89
[TEK, FN1, ITGB3]	0 (0.0%)	0.08	0.70	0.11	0.89
[FGFR1, BCL11A, FGFR3]	0 (0.0%)	0.07	0.67	0.14	0.88
[COL6A2, TNC, ITGB3]	1 (0.79%)	0.07	0.76	0.05	0.88
[ERBB2, PIK3C2G, PIK3R1]	0 (0.0%)	0.17	0.37	0.35	0.88
[ERBB2, DOCK1, PIK3R1]	0 (0.0%)	0.15	0.40	0.32	0.87
[PIK3C2G, PIK3CA, PIK3R1]	0 (0.0%)	0.17	0.38	0.32	0.87
[ERBB2, PIK3C2A, PIK3R1]	0 (0.0%)	0.16	0.39	0.32	0.87
[NF1, MET, FGFR3]	0 (0.0%)	0.29	0.21	0.37	0.86
[PIK3C2G, ITGB3, PIK3R1]	0 (0.0%)	0.15	0.38	0.33	0.86
[RB1, CDKN2A, CHEK2]	0 (0.0%)	0.20	0.36	0.30	0.86
[COL6A2, TEK, FN1]	0 (0.0%)	0.08	0.67	0.11	0.86
[PDGFRA, COL1A1, ITGB3]	0 (0.0%)	0.08	0.67	0.11	0.86
[NF1, FGFR1, TEK]	0 (0.0%)	0.29	0.21	0.35	0.85
[PDGFRA, COL6A2, ITGB3]	0 (0.0%)	0.07	0.67	0.11	0.85
[PIK3CA, FN1, PIK3R1]	0 (0.0%)	0.15	0.38	0.32	0.85
[PIK3CG, ITGB3, PIK3R1]	0 (0.0%)	0.15	0.40	0.30	0.85
[NF1, TEK, FGFR3]	0 (0.0%)	0.29	0.20	0.35	0.84
[FGFR1, TEK, FGFR3]	0 (0.0%)	0.07	0.61	0.16	0.84
[PIK3CG, PDGFRA, PIK3R1]	0 (0.0%)	0.14	0.41	0.29	0.83
[RB1, CDKN2A, PRKDC]	0 (0.0%)	0.20	0.36	0.27	0.83
[FN1, TNC, ITGB3]	2 (1.59%)	0.06	0.73	0.03	0.83
[NF1, FGFR1, PDGFRA]	0 (0.0%)	0.28	0.19	0.37	0.83
[NF1, FGFR1, MET]	0 (0.0%)	0.29	0.21	0.33	0.83
[PIK3CG, BCR, PIK3R1]	0 (0.0%)	0.14	0.40	0.29	0.83
[COL6A2, PIK3C2A, ITGB3]	0 (0.0%)	0.08	0.67	0.08	0.83
[PDGFRA, FN1, ITGB3]	0 (0.0%)	0.06	0.67	0.10	0.83
[PDGFRA, TNC, ITGB3]	0 (0.0%)	0.06	0.67	0.10	0.83
[NF1, MET, PDGFRA]	0 (0.0%)	0.29	0.17	0.37	0.83
[PIK3C2G, HLA-E, PIK3R1]	0 (0.0%)	0.14	0.37	0.32	0.82
[FGFR1, PIK3C2G, PIK3R1]	0 (0.0%)	0.14	0.37	0.32	0.82
[PDGFRA, PIK3C2G, PIK3R1]	0 (0.0%)	0.14	0.37	0.32	0.82
[PIK3C2G, FGFR3, PIK3R1]	0 (0.0%)	0.14	0.37	0.32	0.82
[PDGFRA, EGFR, BCR]	0 (0.0%)	0.19	0.17	0.46	0.82
[PIK3C2A, FGFR3, PIK3R1]	0 (0.0%)	0.14	0.40	0.29	0.82
[ERBB2, FN1, PIK3R1]	0 (0.0%)	0.15	0.38	0.29	0.81
[PIK3CG, MET, PIK3R1]	1 (0.79%)	0.15	0.41	0.25	0.81
[BCR, DOCK1, PIK3R1]	0 (0.0%)	0.13	0.40	0.29	0.81
[PDGFRA, DOCK1, PIK3R1]	0 (0.0%)	0.13	0.40	0.29	0.81
[DOCK1, FGFR3, PIK3R1]	0 (0.0%)	0.13	0.40	0.29	0.81
[DOCK1, HLA-E, PIK3R1]	0 (0.0%)	0.13	0.40	0.29	0.81
[PDGFRA, PIK3C2A, PIK3R1]	0 (0.0%)	0.14	0.39	0.29	0.81
[FGFR1, RB1, CDKN2A]	0 (0.0%)	0.19	0.35	0.27	0.81
[FGFR1, PIK3C2A, PIK3R1]	0 (0.0%)	0.14	0.39	0.29	0.81
[RB1, CDKN2A, FGFR3]	0 (0.0%)	0.19	0.35	0.27	0.81
[CDKN2A, PIK3C2G, PIK3R1]	0 (0.0%)	0.16	0.37	0.29	0.81
[RB1, CDKN2A, TEK]	0 (0.0%)	0.20	0.35	0.25	0.81
[PIK3C2A, COL1A1, ITGB3]	0 (0.0%)	0.09	0.67	0.05	0.81
[PIK3C2A, FN1, ITGB3]	1 (0.79%)	0.07	0.67	0.06	0.80
[PIK3C2A, TNC, ITGB3]	1 (0.79%)	0.07	0.67	0.06	0.80
[PIK3CG, HLA-E, PIK3R1]	0 (0.0%)	0.14	0.38	0.29	0.80
[CDKN2A, CHEK2, PIK3R1]	0 (0.0%)	0.16	0.36	0.29	0.80
[MET, PIK3C2G, PIK3R1]	0 (0.0%)	0.15	0.37	0.29	0.80
[EGFR, FGFR3, ITPR3]	0 (0.0%)	0.19	0.13	0.48	0.80
[NF1, PDGFRA, TEK]	0 (0.0%)	0.29	0.15	0.35	0.80
[PIK3CG, ERBB2, MET]	0 (0.0%)	0.11	0.51	0.17	0.80
[EGFR, TEK, ITGB3]	0 (0.0%)	0.21	0.12	0.46	0.80
[PIK3CG, ERBB2, TEK]	0 (0.0%)	0.11	0.46	0.22	0.80
[PIK3CG, TEK, PIK3R1]	0 (0.0%)	0.16	0.40	0.24	0.79
[NF1, MET, TEK]	0 (0.0%)	0.30	0.17	0.32	0.79
[PIK3C2G, TEK, PIK3R1]	0 (0.0%)	0.16	0.37	0.27	0.79
[PIK3CG, CDKN2A, PIK3R1]	1 (0.79%)	0.16	0.38	0.25	0.79
[BCR, PIK3C2G, PIK3R1]	0 (0.0%)	0.14	0.37	0.29	0.79
[PDGFRA, ERBB2, ITGB3]	0 (0.0%)	0.09	0.48	0.22	0.79
[PIK3C2A, HLA-E, PIK3R1]	0 (0.0%)	0.14	0.37	0.29	0.79
[PIK3C2A, BCR, PIK3R1]	0 (0.0%)	0.14	0.37	0.29	0.79
[ERBB2, EPHA7, PIK3R1]	0 (0.0%)	0.15	0.35	0.29	0.79
[ERBB2, TEK, FN1]	0 (0.0%)	0.10	0.46	0.22	0.78
[EGFR, BCR, FGFR3]	0 (0.0%)	0.19	0.13	0.46	0.78
[PDGFRA, EGFR, FN1]	0 (0.0%)	0.19	0.16	0.43	0.78
[DOCK1, TEK, PIK3R1]	0 (0.0%)	0.14	0.40	0.24	0.78
[FGFR1, DOCK1, PIK3R1]	0 (0.0%)	0.13	0.40	0.25	0.78
[EGFR, FGFR3, ITGB3]	0 (0.0%)	0.19	0.17	0.41	0.78
[EGFR, FGFR1, ITPR3]	0 (0.0%)	0.19	0.11	0.48	0.78
[MET, FGFR1, FGFR3]	0 (0.0%)	0.07	0.60	0.11	0.78
[PIK3CG, ERBB2, PDGFRA]	0 (0.0%)	0.10	0.47	0.21	0.78
[ERBB2, FGFR1, BCL11A]	0 (0.0%)	0.10	0.47	0.21	0.78
[CDKN2A, PRKDC, PIK3R1]	1 (0.79%)	0.16	0.36	0.25	0.78
[PDGFRA, FGFR1, FGFR3]	0 (0.0%)	0.06	0.61	0.11	0.77
[EGFR, BCR, TEK]	0 (0.0%)	0.20	0.09	0.48	0.77
[DOCK1, ITGB3, PIK3R1]	0 (0.0%)	0.13	0.40	0.24	0.77
[PIK3CG, FGFR1, TEK]	0 (0.0%)	0.09	0.49	0.19	0.77
[PIK3CG, PDGFRA, FGFR3]	0 (0.0%)	0.07	0.52	0.17	0.77
[NF1, FGFR1, BCR]	0 (0.0%)	0.28	0.09	0.40	0.77
[CDKN2A, DOCK1, PIK3R1]	0 (0.0%)	0.15	0.40	0.22	0.77
[NF1, BCR, FGFR3]	0 (0.0%)	0.28	0.09	0.40	0.77
[PIK3CG, TEK, FGFR3]	0 (0.0%)	0.09	0.49	0.19	0.76
[FGFR1, EGFR, BCR]	0 (0.0%)	0.19	0.12	0.46	0.76
[MET, PIK3C2A, PIK3R1]	0 (0.0%)	0.15	0.40	0.22	0.76
[EGFR, FGFR1, ITGB3]	0 (0.0%)	0.19	0.16	0.41	0.76
[EGFR, CDKN2A, FGFR3]	0 (0.0%)	0.21	0.13	0.43	0.76
[MET, EGFR, BCR]	0 (0.0%)	0.20	0.13	0.43	0.76
[MET, EGFR, ITGB3]	1 (0.79%)	0.20	0.17	0.38	0.76
[PIK3C2A, TEK, PIK3R1]	0 (0.0%)	0.15	0.37	0.24	0.76
[NF1, CDKN2A, FGFR1]	0 (0.0%)	0.30	0.09	0.37	0.75
[NF1, CDKN2A, FGFR3]	0 (0.0%)	0.30	0.09	0.37	0.75
[EGFR, CDKN2A, TEK]	0 (0.0%)	0.22	0.08	0.44	0.75
[ERBB2, DOCK1, PIK3CA]	0 (0.0%)	0.11	0.40	0.24	0.75
[PIK3CG, TEK, PIK3CA]	0 (0.0%)	0.11	0.41	0.22	0.75
[NF1, PDGFRA, BCR]	0 (0.0%)	0.28	0.07	0.40	0.75
[CDKN2A, PIK3C2A, PIK3R1]	0 (0.0%)	0.16	0.37	0.22	0.75
[MET, DOCK1, PIK3R1]	0 (0.0%)	0.14	0.42	0.19	0.74
[FGFR1, EGFR, CDKN2A]	0 (0.0%)	0.21	0.11	0.43	0.74
[EGFR, FN1, FGFR3]	0 (0.0%)	0.19	0.13	0.43	0.74
[BCR, PRAME, PIK3R1]	0 (0.0%)	0.13	0.36	0.25	0.74
[PIK3CG, PIK3CA, ITGB3]	0 (0.0%)	0.10	0.41	0.22	0.74
[COL1A1, FN1, PIK3R1]	0 (0.0%)	0.14	0.36	0.24	0.74
[PDGFRA, FN1, PIK3R1]	0 (0.0%)	0.13	0.36	0.25	0.74
[HLA-E, FN1, PIK3R1]	0 (0.0%)	0.13	0.36	0.25	0.74
[FGFR3, FN1, PIK3R1]	0 (0.0%)	0.13	0.36	0.25	0.74
[FGFR1, FN1, PIK3R1]	0 (0.0%)	0.13	0.36	0.25	0.74
[EGFR, PIK3C2G, ITGB3]	0 (0.0%)	0.21	0.05	0.48	0.73
[NF1, FGFR1, ITPR3]	0 (0.0%)	0.28	0.07	0.38	0.73
[NF1, MET, BCR]	0 (0.0%)	0.29	0.08	0.37	0.73
[MET, ERBB2, FGFR3]	0 (0.0%)	0.09	0.43	0.21	0.73
[ERBB2, PIK3C2A, PIK3CA]	0 (0.0%)	0.12	0.37	0.24	0.73
[NF1, FGFR3, ITPR3]	0 (0.0%)	0.28	0.07	0.38	0.73
[EGFR, TEK, EPHA7]	0 (0.0%)	0.20	0.08	0.44	0.73
[NF1, PIK3C2A, FGFR3]	0 (0.0%)	0.29	0.08	0.37	0.73
[PIK3CG, PDGFRA, PIK3CA]	0 (0.0%)	0.10	0.42	0.21	0.73
[PDGFRA, TEK, ITGB3]	0 (0.0%)	0.08	0.47	0.17	0.73
[PIK3CG, MET, FGFR3]	0 (0.0%)	0.08	0.50	0.14	0.73
[FGFR1, ITPR3, PIK3R1]	0 (0.0%)	0.13	0.35	0.24	0.73
[ITPR3, FGFR3, PIK3R1]	0 (0.0%)	0.13	0.35	0.24	0.72
[ERBB2, PIK3CA, FN1]	0 (0.0%)	0.11	0.38	0.24	0.72
[EGFR, FGFR1, FN1]	0 (0.0%)	0.19	0.11	0.43	0.72
[DOCK1, TEK, PIK3CA]	0 (0.0%)	0.10	0.40	0.22	0.72
[BCR, FN1, PIK3R1]	0 (0.0%)	0.13	0.37	0.22	0.72
[NF1, FGFR1, PIK3C2A]	0 (0.0%)	0.29	0.07	0.37	0.72
[NF1, BCR, PRAME]	0 (0.0%)	0.28	0.05	0.40	0.72
[PIK3CG, BCR, PIK3CA]	0 (0.0%)	0.10	0.42	0.21	0.72
[PDGFRA, FGFR3, ITGB3]	0 (0.0%)	0.06	0.53	0.13	0.72
[NF1, FGFR1, ITGB3]	0 (0.0%)	0.28	0.08	0.35	0.72
[ITPR3, ITGB3, PIK3R1]	0 (0.0%)	0.14	0.35	0.22	0.72
[PIK3CG, ERBB2, ITGB3]	0 (0.0%)	0.10	0.39	0.22	0.71
[MET, EGFR, EPHA7]	0 (0.0%)	0.20	0.12	0.40	0.71
[NF1, FGFR3, ITGB3]	0 (0.0%)	0.28	0.08	0.35	0.71
[NF1, BCR, TEK]	0 (0.0%)	0.29	0.07	0.35	0.71
[NF1, CDKN2A, PDGFRA]	0 (0.0%)	0.30	0.05	0.37	0.71
[CDKN2A, PIK3CA, CHEK2]	0 (0.0%)	0.12	0.36	0.24	0.71
[ERBB2, TEK, FGFR3]	0 (0.0%)	0.10	0.39	0.22	0.71
[MET, ERBB2, TEK]	0 (0.0%)	0.11	0.38	0.22	0.71
[MET, EPHA7, PIK3R1]	0 (0.0%)	0.14	0.35	0.22	0.71
[ERBB2, FGFR1, TEK]	0 (0.0%)	0.10	0.39	0.22	0.71
[MET, EGFR, FN1]	1 (0.79%)	0.20	0.15	0.37	0.71
[MET, FN1, PIK3R1]	1 (0.79%)	0.14	0.38	0.19	0.71
[FGFR1, TEK, FN1]	0 (0.0%)	0.07	0.47	0.16	0.71
[PIK3CG, MET, PIK3CA]	0 (0.0%)	0.11	0.42	0.17	0.71
[PDGFRA, ERBB2, FGFR3]	0 (0.0%)	0.08	0.41	0.21	0.71
[NF1, PDGFRA, PIK3C2A]	0 (0.0%)	0.29	0.05	0.37	0.70
[EPHA7, TEK, PIK3R1]	0 (0.0%)	0.14	0.35	0.21	0.70
[FGFR3, TEK, FN1]	0 (0.0%)	0.07	0.47	0.16	0.70
[NF1, MET, EPHA7]	0 (0.0%)	0.29	0.05	0.37	0.70
[PIK3CG, ERBB2, PIK3C2G]	0 (0.0%)	0.11	0.35	0.24	0.70
[ERBB2, PIK3CA, EPHA7]	0 (0.0%)	0.11	0.35	0.24	0.70
[PIK3C2A, PIK3C2G, ITGB3]	0 (0.0%)	0.09	0.45	0.16	0.70
[NF1, CDKN2A, PRKDC]	0 (0.0%)	0.31	0.05	0.33	0.70
[PIK3CG, HLA-E, PIK3CA]	0 (0.0%)	0.10	0.39	0.21	0.70
[COL6A2, FN1, PIK3R1]	0 (0.0%)	0.13	0.36	0.21	0.69
[PIK3CG, FGFR1, PDGFRA]	0 (0.0%)	0.07	0.48	0.14	0.69
[NF1, CDKN2A, TEK]	0 (0.0%)	0.31	0.06	0.32	0.69
[FGFR3, DOCK1, PIK3CA]	0 (0.0%)	0.08	0.40	0.21	0.69
[DOCK1, HLA-E, PIK3CA]	0 (0.0%)	0.08	0.40	0.21	0.69
[PDGFRA, DOCK1, PIK3CA]	0 (0.0%)	0.08	0.40	0.21	0.69
[BCR, DOCK1, PIK3CA]	0 (0.0%)	0.08	0.40	0.21	0.69
[NF1, CDKN2A, CHEK2]	0 (0.0%)	0.31	0.05	0.33	0.69
[PIK3CG, ERBB2, BCR]	0 (0.0%)	0.10	0.39	0.21	0.69
[PIK3CG, FGFR1, MET]	0 (0.0%)	0.08	0.50	0.11	0.69
[FGFR1, TEK, BCL11A]	0 (0.0%)	0.09	0.47	0.13	0.69
[PIK3C2A, TEK, PIK3CA]	0 (0.0%)	0.11	0.36	0.22	0.69
[MET, ERBB2, FGFR1]	0 (0.0%)	0.09	0.42	0.17	0.69
[NF1, MET, PIK3C2A]	1 (0.79%)	0.30	0.06	0.33	0.69
[FGFR3, PIK3C2A, PIK3CA]	0 (0.0%)	0.09	0.39	0.21	0.69
[PIK3CG, CDKN2A, PIK3CA]	0 (0.0%)	0.12	0.39	0.17	0.68
[NF1, TEK, ITGB3]	0 (0.0%)	0.30	0.05	0.33	0.68
[ERBB2, PIK3C2G, PIK3CA]	0 (0.0%)	0.12	0.35	0.21	0.68
[EGFR, ITPR3, ITGB3]	0 (0.0%)	0.20	0.05	0.43	0.68
[MET, EGFR, DOCK1]	1 (0.79%)	0.20	0.12	0.37	0.68
[NF1, MET, ITGB3]	1 (0.79%)	0.29	0.07	0.32	0.68
[NF1, TEK, EPHA7]	0 (0.0%)	0.29	0.04	0.35	0.68
[CDKN2A, DOCK1, PIK3CA]	0 (0.0%)	0.10	0.40	0.17	0.68
[PDGFRA, PIK3C2A, PIK3CA]	0 (0.0%)	0.09	0.38	0.21	0.68
[FGFR1, PIK3C2A, PIK3CA]	0 (0.0%)	0.09	0.38	0.21	0.68
[PDGFRA, ERBB2, MET]	0 (0.0%)	0.09	0.38	0.21	0.68
[ERBB2, PIK3C2A, ITGB3]	0 (0.0%)	0.10	0.39	0.19	0.68
[PDGFRA, TEK, FN1]	0 (0.0%)	0.07	0.44	0.16	0.68
[NF1, CDKN2A, BCR]	0 (0.0%)	0.30	0.04	0.33	0.67
[TEK, PIK3CA, EPHA7]	0 (0.0%)	0.10	0.35	0.22	0.67
[NF1, BCR, ITGB3]	0 (0.0%)	0.28	0.04	0.35	0.67
[FGFR1, PIK3CA, ITPR3]	0 (0.0%)	0.09	0.35	0.22	0.67
[FGFR3, PIK3CA, ITPR3]	0 (0.0%)	0.09	0.35	0.22	0.67
[PIK3CG, ERBB2, PIK3C2A]	0 (0.0%)	0.11	0.35	0.21	0.66
[PIK3C2G, PIK3CA, ITGB3]	0 (0.0%)	0.10	0.37	0.19	0.66
[PDGFRA, MET, ITGB3]	0 (0.0%)	0.07	0.49	0.10	0.66
[MET, PIK3C2A, PIK3CA]	0 (0.0%)	0.10	0.38	0.17	0.66
[NF1, CDKN2A, MET]	1 (0.79%)	0.31	0.05	0.30	0.66
[MET, TEK, FN1]	0 (0.0%)	0.08	0.48	0.10	0.66
[CDKN2A, FN1, PIK3R1]	1 (0.79%)	0.15	0.36	0.16	0.66
[FGFR1, DOCK1, PIK3CA]	0 (0.0%)	0.08	0.40	0.17	0.66
[MET, FGFR1, BCL11A]	1 (0.79%)	0.08	0.46	0.11	0.66
[ITPR3, PIK3CA, ITGB3]	0 (0.0%)	0.10	0.35	0.21	0.66
[PIK3C2G, TEK, PIK3CA]	0 (0.0%)	0.11	0.35	0.19	0.66
[EGFR, BCR, ITGB3]	0 (0.0%)	0.19	0.05	0.41	0.66
[PIK3C2A, PIK3CA, BCR]	0 (0.0%)	0.09	0.36	0.21	0.66
[PIK3C2A, HLA-E, PIK3CA]	0 (0.0%)	0.09	0.36	0.21	0.66
[MET, DOCK1, PIK3CA]	0 (0.0%)	0.09	0.42	0.14	0.65
[PIK3CG, ERBB2, EPHA7]	0 (0.0%)	0.10	0.35	0.21	0.65
[CDKN2A, PRKDC, PIK3CA]	0 (0.0%)	0.12	0.36	0.17	0.65
[PIK3CG, PDGFRA, ITGB3]	0 (0.0%)	0.08	0.39	0.19	0.65
[MET, PIK3CA, EPHA7]	0 (0.0%)	0.09	0.35	0.21	0.65
[BCR, PIK3CA, PRAME]	0 (0.0%)	0.08	0.36	0.21	0.65
[DOCK1, PIK3CA, ITGB3]	0 (0.0%)	0.09	0.40	0.16	0.65
[ERBB2, COL1A1, ITGB3]	0 (0.0%)	0.11	0.37	0.17	0.65
[NF1, BCR, FN1]	0 (0.0%)	0.28	0.04	0.33	0.65
[PDGFRA, ERBB2, TEK]	0 (0.0%)	0.10	0.32	0.22	0.65
[PIK3C2G, ANK2, ITPR3]	0 (0.0%)	0.08	0.38	0.19	0.65
[PIK3CA, FN1, COL1A1]	0 (0.0%)	0.10	0.36	0.19	0.65
[FGFR1, PIK3CA, FN1]	0 (0.0%)	0.08	0.36	0.21	0.65
[PDGFRA, PIK3CA, FN1]	0 (0.0%)	0.08	0.36	0.21	0.65
[FGFR3, PIK3CA, FN1]	0 (0.0%)	0.08	0.36	0.21	0.65
[HLA-E, PIK3CA, FN1]	0 (0.0%)	0.08	0.36	0.21	0.65
[ERBB2, COL1A1, FN1]	0 (0.0%)	0.10	0.35	0.19	0.65
[NF1, MET, FN1]	1 (0.79%)	0.29	0.06	0.30	0.64
[CDKN2A, PIK3C2G, PIK3CA]	0 (0.0%)	0.12	0.35	0.17	0.64
[CDKN2A, PIK3C2A, PIK3CA]	0 (0.0%)	0.11	0.36	0.17	0.64
[PDGFRA, FGFR1, ITGB3]	0 (0.0%)	0.06	0.48	0.10	0.64
[PIK3CG, ERBB2, CDKN2A]	0 (0.0%)	0.12	0.35	0.17	0.64
[PIK3CG, PIK3C2G, FGFR3]	0 (0.0%)	0.08	0.35	0.21	0.64
[PIK3CG, FGFR1, PIK3C2G]	0 (0.0%)	0.08	0.35	0.21	0.64
[ERBB2, COL6A2, ITGB3]	0 (0.0%)	0.10	0.37	0.17	0.64
[EGFR, FN1, TNC]	1 (0.79%)	0.19	0.08	0.37	0.64
[ERBB2, FN1, ITGB3]	0 (0.0%)	0.09	0.39	0.16	0.64
[COL6A2, PIK3CA, FN1]	0 (0.0%)	0.09	0.36	0.19	0.64
[ERBB2, COL6A2, FN1]	0 (0.0%)	0.09	0.35	0.19	0.64
[NF1, MET, DOCK1]	1 (0.79%)	0.29	0.05	0.30	0.64
[MET, PIK3C2G, PIK3CA]	0 (0.0%)	0.11	0.35	0.17	0.63
[FN1, COL1A1, TNC]	1 (0.79%)	0.07	0.50	0.06	0.63
[MET, TEK, FGFR3]	0 (0.0%)	0.08	0.39	0.16	0.63
[PDGFRA, TEK, FGFR3]	0 (0.0%)	0.07	0.40	0.16	0.63
[PIK3C2A, PIK3C2G, PIK3R1]	0 (0.0%)	0.15	0.17	0.32	0.63
[BCR, PIK3CA, FN1]	0 (0.0%)	0.08	0.37	0.17	0.63
[PIK3CG, FGFR1, BCR]	0 (0.0%)	0.07	0.39	0.17	0.63
[PIK3CG, BCR, FGFR3]	0 (0.0%)	0.07	0.38	0.17	0.63
[PDGFRA, FGFR1, BCL11A]	0 (0.0%)	0.07	0.45	0.11	0.63
[PIK3CG, ERBB2, FN1]	0 (0.0%)	0.10	0.35	0.17	0.63
[PIK3CG, FGFR1, ITGB3]	0 (0.0%)	0.08	0.39	0.16	0.63
[PDGFRA, PIK3C2G, PIK3CA]	0 (0.0%)	0.10	0.35	0.17	0.62
[FGFR1, PIK3C2G, PIK3CA]	0 (0.0%)	0.10	0.35	0.17	0.62
[FGFR3, PIK3C2G, PIK3CA]	0 (0.0%)	0.10	0.35	0.17	0.62
[PIK3C2G, HLA-E, PIK3CA]	0 (0.0%)	0.10	0.35	0.17	0.62
[PIK3CG, FGFR3, ITGB3]	0 (0.0%)	0.08	0.39	0.16	0.62
[PDGFRA, MET, FGFR3]	0 (0.0%)	0.07	0.41	0.14	0.62
[COL6A2, FN1, TNC]	1 (0.79%)	0.06	0.49	0.06	0.62
[EGFR, BCR, FN1]	0 (0.0%)	0.19	0.04	0.40	0.62
[PDGFRA, ERBB2, FGFR1]	0 (0.0%)	0.08	0.36	0.17	0.62
[PDGFRA, PIK3C2G, ITGB3]	0 (0.0%)	0.08	0.35	0.19	0.62
[PIK3CG, PIK3C2A, FGFR3]	0 (0.0%)	0.08	0.36	0.17	0.62
[MET, PIK3CA, FN1]	0 (0.0%)	0.09	0.38	0.14	0.62
[ERBB2, TNC, ITGB3]	0 (0.0%)	0.09	0.37	0.16	0.62
[PIK3CG, FGFR1, PIK3C2A]	0 (0.0%)	0.08	0.36	0.17	0.61
[MET, FGFR1, TEK]	0 (0.0%)	0.08	0.39	0.13	0.60
[PIK3CG, PIK3C2A, ITGB3]	0 (0.0%)	0.09	0.35	0.16	0.60
[PIK3CG, TEK, FN1]	0 (0.0%)	0.09	0.35	0.16	0.60
[FGFR1, FGFR3, ITPR3]	0 (0.0%)	0.06	0.37	0.16	0.60
[PIK3C2A, TEK, ITGB3]	0 (0.0%)	0.09	0.36	0.14	0.60
[FGFR1, PIK3C2A, FGFR3]	0 (0.0%)	0.07	0.38	0.14	0.60
[CDKN2A, FGFR1, FGFR3]	0 (0.0%)	0.08	0.37	0.14	0.59
[BCR, PIK3C2G, PIK3CA]	0 (0.0%)	0.10	0.35	0.14	0.59
[PDGFRA, MET, TEK]	0 (0.0%)	0.08	0.35	0.16	0.59
[PIK3CG, FGFR1, ITPR3]	0 (0.0%)	0.08	0.35	0.16	0.59
[PIK3CG, COL1A1, ITGB3]	0 (0.0%)	0.09	0.35	0.14	0.59
[PIK3CG, FGFR3, ITPR3]	0 (0.0%)	0.08	0.35	0.16	0.59
[FGFR1, BCR, FGFR3]	0 (0.0%)	0.06	0.39	0.14	0.59
[PIK3C2G, COL1A1, ITGB3]	0 (0.0%)	0.09	0.35	0.14	0.59
[TEK, COL1A1, ITGB3]	0 (0.0%)	0.10	0.36	0.13	0.59
[PIK3CG, CDKN2A, FGFR1]	0 (0.0%)	0.09	0.35	0.14	0.59
[PIK3CG, CDKN2A, FGFR3]	0 (0.0%)	0.09	0.35	0.14	0.59
[BCR, TEK, FN1]	0 (0.0%)	0.07	0.38	0.13	0.58
[PIK3CG, COL6A2, ITGB3]	0 (0.0%)	0.08	0.35	0.14	0.58
[FGFR1, PIK3C2A, BCL11A]	0 (0.0%)	0.08	0.36	0.14	0.58
[COL6A2, PIK3C2G, ITGB3]	0 (0.0%)	0.08	0.35	0.14	0.58
[ANK2, FGFR3, ITPR3]	0 (0.0%)	0.06	0.35	0.16	0.58
[CYP27B1, ANK2, ITPR3]	0 (0.0%)	0.06	0.35	0.16	0.58
[CDKN2A, PIK3CA, FN1]	0 (0.0%)	0.10	0.36	0.11	0.57
[TEK, FN1, TNC]	0 (0.0%)	0.07	0.40	0.10	0.57
[PDGFRA, BCR, ITGB3]	0 (0.0%)	0.06	0.38	0.13	0.57
[PDGFRA, ITPR3, ITGB3]	0 (0.0%)	0.07	0.35	0.14	0.57
[PIK3C2A, FGFR3, ITGB3]	0 (0.0%)	0.07	0.40	0.10	0.57
[PDGFRA, FGFR1, TEK]	0 (0.0%)	0.07	0.36	0.13	0.56
[PIK3CG, PIK3C2G, PIK3R1]	0 (0.0%)	0.15	0.09	0.32	0.56
[FGFR1, FGFR3, ITGB3]	0 (0.0%)	0.06	0.40	0.10	0.56
[FGFR1, PIK3C2A, ITGB3]	0 (0.0%)	0.07	0.39	0.10	0.56
[PIK3C2A, ANK2, ITPR3]	0 (0.0%)	0.07	0.36	0.13	0.56
[PIK3CG, TNC, ITGB3]	0 (0.0%)	0.08	0.35	0.13	0.56
[PIK3C2G, DOCK1, PIK3R1]	0 (0.0%)	0.14	0.10	0.32	0.56
[PIK3C2G, TNC, ITGB3]	0 (0.0%)	0.08	0.35	0.13	0.56
[PIK3C2G, FN1, ITGB3]	0 (0.0%)	0.08	0.35	0.13	0.56
[CDKN2A, FGFR1, BCL11A]	0 (0.0%)	0.09	0.35	0.11	0.56
[TEK, TNC, ITGB3]	0 (0.0%)	0.08	0.36	0.11	0.56
[TEK, FN1, EPHA7]	0 (0.0%)	0.07	0.35	0.13	0.55
[COL6A2, COL1A1, TNC]	1 (0.79%)	0.08	0.39	0.08	0.55
[MET, PIK3C2A, ITGB3]	1 (0.79%)	0.08	0.40	0.06	0.55
[FGFR1, ANK2, ITPR3]	0 (0.0%)	0.06	0.35	0.13	0.55
[COL6A2, TEK, ITGB3]	0 (0.0%)	0.09	0.36	0.10	0.55
[FGFR1, BCR, BCL11A]	0 (0.0%)	0.07	0.36	0.11	0.54
[FGFR1, BCL11A, ITGB3]	1 (0.79%)	0.08	0.37	0.10	0.54
[PIK3C2A, ITPR3, ITGB3]	0 (0.0%)	0.08	0.38	0.08	0.54
[PIK3CG, DOCK1, PIK3R1]	0 (0.0%)	0.14	0.11	0.29	0.54
[ITPR3, COL1A1, ITGB3]	1 (0.79%)	0.09	0.35	0.10	0.54
[ITPR3, ANK2, ITGB3]	0 (0.0%)	0.07	0.35	0.11	0.54
[FGFR1, COL1A1, ITGB3]	1 (0.79%)	0.08	0.37	0.08	0.53
[FGFR3, COL1A1, ITGB3]	0 (0.0%)	0.08	0.37	0.08	0.53
[FGFR1, BCL11A, ITPR3]	0 (0.0%)	0.08	0.35	0.10	0.53
[PIK3CG, FN1, ITGB3]	0 (0.0%)	0.08	0.35	0.10	0.53
[BCR, COL1A1, FN1]	1 (0.79%)	0.07	0.35	0.10	0.52
[COL6A2, FGFR1, ITGB3]	1 (0.79%)	0.07	0.37	0.08	0.52
[PIK3C2A, BCR, ITGB3]	0 (0.0%)	0.07	0.35	0.10	0.52
[COL6A2, FGFR3, ITGB3]	0 (0.0%)	0.07	0.37	0.08	0.52
[ERBB2, TEK, ITGB3]	0 (0.0%)	0.11	0.17	0.24	0.52
[PIK3CG, PIK3C2A, PIK3R1]	0 (0.0%)	0.15	0.08	0.29	0.51
[MET, COL1A1, ITGB3]	1 (0.79%)	0.09	0.37	0.05	0.51
[COL6A2, BCR, FN1]	1 (0.79%)	0.06	0.35	0.10	0.51
[PDGFRA, FGFR1, MET]	0 (0.0%)	0.07	0.36	0.08	0.51
[BCR, COL1A1, ITGB3]	1 (0.79%)	0.08	0.35	0.08	0.51
[MET, ERBB2, BCR]	0 (0.0%)	0.09	0.21	0.21	0.51
[CDKN2A, TEK, FN1]	0 (0.0%)	0.09	0.35	0.06	0.51
[ITPR3, TNC, ITGB3]	1 (0.79%)	0.07	0.35	0.08	0.50
[MET, COL6A2, ITGB3]	1 (0.79%)	0.08	0.37	0.05	0.50
[COL6A2, BCR, ITGB3]	1 (0.79%)	0.07	0.35	0.08	0.50
[FGFR1, FN1, ITGB3]	0 (0.0%)	0.06	0.37	0.06	0.50
[FGFR1, TNC, ITGB3]	0 (0.0%)	0.06	0.37	0.06	0.50
[BCR, FN1, ITGB3]	1 (0.79%)	0.06	0.37	0.06	0.50
[ERBB2, FGFR3, ITGB3]	0 (0.0%)	0.09	0.21	0.19	0.50
[FGFR3, FN1, ITGB3]	0 (0.0%)	0.06	0.37	0.06	0.50
[FGFR3, TNC, ITGB3]	0 (0.0%)	0.06	0.37	0.06	0.50
[ERBB2, PIK3C2A, FGFR3]	0 (0.0%)	0.09	0.19	0.21	0.49
[COL6A2, ITPR3, ITGB3]	1 (0.79%)	0.08	0.35	0.06	0.49
[ERBB2, BCR, FGFR3]	0 (0.0%)	0.08	0.20	0.21	0.49
[PIK3C2G, ITPR3, PIK3R1]	0 (0.0%)	0.15	0.08	0.27	0.49
[ERBB2, CDKN2A, FGFR3]	0 (0.0%)	0.10	0.18	0.21	0.49
[PIK3C2A, ROR2, ITGB3]	1 (0.79%)	0.07	0.35	0.06	0.49
[PIK3C2A, DOCK1, PIK3R1]	0 (0.0%)	0.14	0.10	0.25	0.49
[ERBB2, FGFR1, ITGB3]	0 (0.0%)	0.09	0.21	0.19	0.49
[ERBB2, BCR, TEK]	0 (0.0%)	0.10	0.17	0.22	0.49
[FGFR1, ERBB2, BCR]	0 (0.0%)	0.08	0.20	0.21	0.49
[FGFR1, ERBB2, CDKN2A]	0 (0.0%)	0.10	0.18	0.21	0.49
[ERBB2, CDKN2A, TEK]	0 (0.0%)	0.12	0.14	0.22	0.48
[MET, ERBB2, EPHA7]	0 (0.0%)	0.09	0.18	0.21	0.48
[MET, ERBB2, ITGB3]	0 (0.0%)	0.10	0.22	0.16	0.48
[MET, TNC, ITGB3]	1 (0.79%)	0.07	0.37	0.03	0.48
[ERBB2, FGFR3, ITPR3]	0 (0.0%)	0.09	0.17	0.22	0.48
[PIK3C2G, FN1, PIK3R1]	0 (0.0%)	0.14	0.05	0.29	0.48
[FGFR1, ERBB2, PIK3C2A]	0 (0.0%)	0.09	0.18	0.21	0.48
[BCR, TNC, ITGB3]	1 (0.79%)	0.06	0.35	0.06	0.48
[MET, COL1A1, FN1]	0 (0.0%)	0.08	0.36	0.03	0.48
[MET, FN1, ITGB3]	1 (0.79%)	0.07	0.40	0.00	0.47
[MET, ERBB2, PIK3C2A]	0 (0.0%)	0.10	0.19	0.17	0.47
[ERBB2, FGFR1, ITPR3]	0 (0.0%)	0.09	0.16	0.22	0.47
[ITPR3, FN1, ITGB3]	1 (0.79%)	0.07	0.35	0.05	0.47
[MET, COL6A2, FN1]	0 (0.0%)	0.07	0.36	0.03	0.47
[ERBB2, TEK, EPHA7]	0 (0.0%)	0.10	0.14	0.22	0.46
[ERBB2, PIK3C2A, PIK3C2G]	0 (0.0%)	0.11	0.12	0.24	0.46
[PIK3CG, FN1, PIK3R1]	1 (0.79%)	0.14	0.07	0.25	0.46
[ERBB2, FN1, FGFR3]	0 (0.0%)	0.08	0.17	0.21	0.46
[ERBB2, PIK3C2A, TEK]	0 (0.0%)	0.11	0.13	0.22	0.46
[PDGFRA, ERBB2, BCR]	0 (0.0%)	0.08	0.17	0.21	0.46
[ERBB2, FGFR3, EPHA7]	0 (0.0%)	0.08	0.16	0.21	0.45
[ERBB2, FGFR1, FN1]	0 (0.0%)	0.08	0.16	0.21	0.45
[PDGFRA, ERBB2, PIK3C2A]	0 (0.0%)	0.09	0.15	0.21	0.45
[ERBB2, FGFR1, EPHA7]	0 (0.0%)	0.08	0.16	0.21	0.45
[PIK3C2A, ROR2, PIK3R1]	0 (0.0%)	0.14	0.06	0.25	0.45
[DOCK1, FN1, PIK3R1]	0 (0.0%)	0.13	0.09	0.22	0.44
[PIK3CG, PDGFRA, TEK]	0 (0.0%)	0.09	0.16	0.19	0.44
[PDGFRA, ERBB2, CDKN2A]	0 (0.0%)	0.10	0.13	0.21	0.44
[MET, ERBB2, FN1]	0 (0.0%)	0.09	0.20	0.14	0.43
[FGFR1, BCR, TEK]	0 (0.0%)	0.07	0.20	0.16	0.43
[CDKN2A, FGFR1, TEK]	0 (0.0%)	0.09	0.18	0.16	0.43
[PIK3CG, MET, TEK]	0 (0.0%)	0.10	0.17	0.16	0.43
[FGFR1, TEK, ITGB3]	0 (0.0%)	0.08	0.21	0.14	0.43
[PIK3CG, DOCK1, PIK3CA]	0 (0.0%)	0.10	0.13	0.21	0.43
[MET, BCR, TEK]	0 (0.0%)	0.08	0.18	0.16	0.43
[BCR, TEK, FGFR3]	0 (0.0%)	0.07	0.19	0.16	0.42
[CDKN2A, TEK, FGFR3]	0 (0.0%)	0.09	0.17	0.16	0.42
[PIK3C2A, PIK3C2G, PIK3CA]	0 (0.0%)	0.11	0.14	0.17	0.42
[MET, ERBB2, CDKN2A]	0 (0.0%)	0.11	0.17	0.14	0.42
[PDGFRA, PIK3C2A, FGFR3]	0 (0.0%)	0.07	0.21	0.14	0.42
[TEK, FGFR3, ITGB3]	0 (0.0%)	0.08	0.20	0.14	0.42
[PDGFRA, ERBB2, FN1]	0 (0.0%)	0.08	0.13	0.21	0.42
[PIK3CG, PIK3C2A, PIK3C2G]	0 (0.0%)	0.09	0.12	0.21	0.42
[PDGFRA, ERBB2, EPHA7]	0 (0.0%)	0.08	0.13	0.21	0.42
[PIK3C2A, PIK3C2G, ITPR3]	0 (0.0%)	0.09	0.17	0.16	0.42
[PIK3C2A, FN1, PIK3R1]	0 (0.0%)	0.14	0.06	0.22	0.41
[PDGFRA, BCR, FGFR3]	0 (0.0%)	0.06	0.21	0.14	0.41
[ERBB2, PIK3C2G, ITGB3]	0 (0.0%)	0.10	0.05	0.25	0.41
[PIK3CG, MET, PDGFRA]	0 (0.0%)	0.08	0.18	0.14	0.41
[PIK3C2A, ITPR3, PIK3R1]	0 (0.0%)	0.14	0.06	0.21	0.41
[PIK3C2A, TEK, FGFR3]	0 (0.0%)	0.08	0.16	0.16	0.41
[FGFR1, PIK3C2A, TEK]	0 (0.0%)	0.08	0.16	0.16	0.41
[MET, BCR, FGFR3]	0 (0.0%)	0.07	0.19	0.14	0.41
[FN1, TNC, PIK3R1]	0 (0.0%)	0.13	0.09	0.19	0.41
[MET, ERBB2, DOCK1]	0 (0.0%)	0.09	0.17	0.14	0.40
[PDGFRA, FGFR3, ITPR3]	0 (0.0%)	0.06	0.18	0.16	0.40
[MET, TEK, EPHA7]	0 (0.0%)	0.08	0.16	0.16	0.40
[PDGFRA, BCR, TEK]	0 (0.0%)	0.07	0.17	0.16	0.40
[PDGFRA, CDKN2A, FGFR3]	0 (0.0%)	0.08	0.18	0.14	0.40
[PIK3CG, PIK3C2A, PIK3CA]	0 (0.0%)	0.11	0.08	0.21	0.39
[MET, TEK, ITGB3]	0 (0.0%)	0.09	0.19	0.11	0.39
[FGFR1, TEK, EPHA7]	0 (0.0%)	0.07	0.16	0.16	0.39
[PDGFRA, MET, BCR]	0 (0.0%)	0.07	0.18	0.14	0.39
[FGFR1, TEK, ITPR3]	0 (0.0%)	0.08	0.16	0.14	0.39
[PIK3C2A, PIK3C2G, FGFR3]	0 (0.0%)	0.08	0.13	0.17	0.39
[TEK, FGFR3, EPHA7]	0 (0.0%)	0.07	0.15	0.16	0.38
[MET, PIK3C2A, FGFR3]	0 (0.0%)	0.08	0.19	0.11	0.38
[PIK3CG, PIK3C2G, PIK3CA]	0 (0.0%)	0.11	0.09	0.17	0.38
[PDGFRA, CDKN2A, TEK]	0 (0.0%)	0.09	0.13	0.16	0.38
[PDGFRA, PIK3C2A, PIK3C2G]	0 (0.0%)	0.08	0.12	0.17	0.38
[TEK, FGFR3, ITPR3]	0 (0.0%)	0.08	0.15	0.14	0.38
[FGFR1, PIK3C2A, PIK3C2G]	0 (0.0%)	0.08	0.12	0.17	0.38
[PDGFRA, PIK3C2A, TEK]	0 (0.0%)	0.08	0.13	0.16	0.37
[MET, PIK3C2A, TEK]	0 (0.0%)	0.09	0.15	0.13	0.37
[MET, FGFR1, BCR]	0 (0.0%)	0.07	0.19	0.11	0.37
[PIK3CG, TEK, ITGB3]	0 (0.0%)	0.09	0.07	0.21	0.37
[PIK3CG, PIK3C2G, ITGB3]	0 (0.0%)	0.09	0.05	0.22	0.37
[MET, FGFR3, EPHA7]	0 (0.0%)	0.07	0.15	0.14	0.36
[ERBB2, BCR, ITGB3]	0 (0.0%)	0.09	0.08	0.19	0.36
[MET, PIK3C2A, PIK3C2G]	0 (0.0%)	0.09	0.13	0.14	0.36
[PIK3CG, PIK3C2G, TEK]	0 (0.0%)	0.10	0.04	0.22	0.36
[PDGFRA, TEK, EPHA7]	0 (0.0%)	0.07	0.13	0.16	0.36
[PIK3C2G, PIK3CA, ITPR3]	0 (0.0%)	0.10	0.06	0.19	0.36
[PDGFRA, MET, PIK3C2A]	0 (0.0%)	0.08	0.17	0.11	0.36
[PIK3C2G, DOCK1, PIK3CA]	0 (0.0%)	0.10	0.09	0.17	0.36
[PIK3C2A, DOCK1, PIK3CA]	0 (0.0%)	0.09	0.09	0.17	0.36
[MET, FGFR3, ITPR3]	0 (0.0%)	0.07	0.16	0.13	0.36
[ERBB2, ITPR3, ITGB3]	0 (0.0%)	0.10	0.05	0.21	0.36
[PIK3CG, PIK3CA, FN1]	0 (0.0%)	0.10	0.08	0.17	0.35
[PIK3CG, BCR, TEK]	0 (0.0%)	0.09	0.07	0.19	0.35
[MET, FGFR3, ITGB3]	0 (0.0%)	0.07	0.21	0.06	0.35
[ERBB2, PIK3C2A, BCR]	0 (0.0%)	0.09	0.05	0.21	0.35
[DOCK1, PIK3CA, FN1]	0 (0.0%)	0.08	0.09	0.17	0.35
[ERBB2, BCR, PRAME]	0 (0.0%)	0.08	0.06	0.21	0.35
[PIK3C2G, TEK, ITGB3]	0 (0.0%)	0.09	0.05	0.21	0.35
[PDGFRA, MET, EPHA7]	0 (0.0%)	0.07	0.14	0.14	0.35
[MET, FGFR1, ITGB3]	1 (0.79%)	0.07	0.21	0.06	0.35
[PIK3C2A, PIK3C2G, ROR2]	0 (0.0%)	0.08	0.12	0.14	0.35
[BRCA2, PRKDC, CHEK2]	0 (0.0%)	0.08	0.05	0.21	0.34
[PIK3CG, PIK3C2G, ITPR3]	0 (0.0%)	0.09	0.06	0.19	0.34
[PIK3C2G, ITPR3, ITGB3]	0 (0.0%)	0.08	0.08	0.17	0.34
[PIK3CG, PDGFRA, PIK3C2G]	0 (0.0%)	0.08	0.05	0.21	0.34
[CDKN2A, TEK, CHEK2]	0 (0.0%)	0.11	0.04	0.19	0.34
[MET, FGFR1, PIK3C2A]	0 (0.0%)	0.08	0.18	0.08	0.34
[MET, CDKN2A, TEK]	0 (0.0%)	0.10	0.14	0.10	0.34
[PDGFRA, FGFR1, BCR]	0 (0.0%)	0.06	0.17	0.11	0.34
[PIK3C2A, PIK3CA, ITPR3]	0 (0.0%)	0.10	0.05	0.19	0.34
[PDGFRA, FGFR1, PIK3C2A]	0 (0.0%)	0.07	0.16	0.11	0.34
[ERBB2, PIK3C2A, EPHA7]	0 (0.0%)	0.09	0.03	0.21	0.34
[FGFR1, PIK3C2G, ITPR3]	0 (0.0%)	0.08	0.07	0.19	0.33
[PIK3C2G, FGFR3, ITPR3]	0 (0.0%)	0.08	0.07	0.19	0.33
[ERBB2, PIK3C2A, ITPR3]	0 (0.0%)	0.10	0.04	0.19	0.33
[CYP27B1, PIK3C2G, ITPR3]	0 (0.0%)	0.08	0.06	0.19	0.33
[ERBB2, EPHA7, ITGB3]	0 (0.0%)	0.09	0.05	0.19	0.33
[ERBB2, CDKN2A, CHEK2]	0 (0.0%)	0.12	0.04	0.17	0.33
[CDKN2A, PRKDC, CHEK2]	0 (0.0%)	0.10	0.05	0.17	0.33
[PIK3CG, PDGFRA, BCR]	0 (0.0%)	0.07	0.08	0.17	0.33
[MET, FGFR1, EPHA7]	0 (0.0%)	0.07	0.15	0.11	0.33
[ERBB2, BCR, FN1]	0 (0.0%)	0.08	0.07	0.17	0.33
[PDGFRA, FGFR1, ITPR3]	0 (0.0%)	0.06	0.13	0.13	0.33
[ERBB2, CDKN2A, BCR]	0 (0.0%)	0.10	0.05	0.17	0.33
[ERBB2, PIK3C2A, CDKN2A]	0 (0.0%)	0.11	0.03	0.17	0.32
[PDGFRA, CDKN2A, FGFR1]	0 (0.0%)	0.08	0.13	0.11	0.32
[MET, FGFR1, ITPR3]	0 (0.0%)	0.07	0.15	0.10	0.32
[MET, CDKN2A, FGFR3]	0 (0.0%)	0.09	0.16	0.08	0.32
[ERBB2, CDKN2A, ITGB3]	0 (0.0%)	0.11	0.05	0.16	0.32
[MET, TEK, DOCK1]	0 (0.0%)	0.08	0.14	0.10	0.32
[PIK3CG, MET, PIK3C2G]	0 (0.0%)	0.09	0.05	0.17	0.32
[PIK3CG, TEK, EPHA7]	0 (0.0%)	0.09	0.04	0.19	0.32
[FN1, PIK3CA, TNC]	0 (0.0%)	0.08	0.09	0.14	0.32
[ERBB2, FN1, TNC]	0 (0.0%)	0.08	0.09	0.14	0.31
[PIK3C2G, PIK3CA, FN1]	0 (0.0%)	0.10	0.04	0.17	0.31
[PIK3C2A, PIK3CA, FN1]	0 (0.0%)	0.09	0.04	0.17	0.31
[TEK, CDKN2A, PRKDC]	0 (0.0%)	0.11	0.05	0.16	0.31
[PIK3CG, MET, BCR]	0 (0.0%)	0.08	0.09	0.14	0.31
[PIK3C2A, PIK3CA, ROR2]	0 (0.0%)	0.09	0.04	0.17	0.31
[ERBB2, CDKN2A, EPHA7]	0 (0.0%)	0.10	0.03	0.17	0.31
[PIK3CG, PDGFRA, PIK3C2A]	0 (0.0%)	0.08	0.05	0.17	0.31
[MET, FGFR3, FN1]	0 (0.0%)	0.07	0.16	0.08	0.31
[CDKN2A, FGFR1, CHEK2]	0 (0.0%)	0.09	0.04	0.17	0.31
[CDKN2A, FGFR3, CHEK2]	0 (0.0%)	0.09	0.04	0.17	0.31
[ERBB2, PIK3C2A, ROR2]	0 (0.0%)	0.09	0.04	0.17	0.31
[ERBB2, PIK3C2A, FN1]	0 (0.0%)	0.09	0.04	0.17	0.31
[ERBB2, BCR, EPHA7]	0 (0.0%)	0.08	0.05	0.17	0.31
[PIK3CG, CDKN2A, TEK]	0 (0.0%)	0.11	0.04	0.16	0.30
[MET, DOCK1, FGFR3]	0 (0.0%)	0.07	0.15	0.08	0.30
[BCR, TEK, ITGB3]	0 (0.0%)	0.08	0.08	0.14	0.30
[PIK3CG, BCR, PIK3C2G]	0 (0.0%)	0.08	0.04	0.17	0.30
[PIK3CG, BCR, ITGB3]	0 (0.0%)	0.08	0.06	0.16	0.30
[PIK3CG, BCR, PRAME]	0 (0.0%)	0.07	0.05	0.17	0.30
[ERBB2, FN1, EPHA7]	0 (0.0%)	0.08	0.04	0.17	0.30
[CDKN2A, BRCA2, CHEK2]	0 (0.0%)	0.09	0.06	0.14	0.29
[MSH6, BRCA2, CHEK2]	0 (0.0%)	0.08	0.06	0.16	0.29
[PDGFRA, MET, FN1]	0 (0.0%)	0.07	0.14	0.08	0.29
[BCR, TEK, PRAME]	0 (0.0%)	0.07	0.06	0.16	0.29
[FGFR1, PIK3C2G, ITGB3]	0 (0.0%)	0.08	0.05	0.16	0.29
[PIK3C2G, FGFR3, ITGB3]	0 (0.0%)	0.08	0.05	0.16	0.29
[MET, CDKN2A, FGFR1]	0 (0.0%)	0.09	0.15	0.05	0.29
[PDGFRA, MET, DOCK1]	0 (0.0%)	0.07	0.14	0.08	0.28
[CDKN2A, FGFR1, PRKDC]	0 (0.0%)	0.09	0.05	0.14	0.28
[CDKN2A, PRKDC, FGFR3]	0 (0.0%)	0.09	0.05	0.14	0.28
[PIK3CG, MET, ITGB3]	0 (0.0%)	0.09	0.09	0.10	0.28
[PIK3C2A, FGFR3, ITPR3]	0 (0.0%)	0.07	0.07	0.13	0.28
[PIK3CG, MET, EPHA7]	0 (0.0%)	0.08	0.05	0.14	0.27
[ERBB2, CDKN2A, PRKDC]	0 (0.0%)	0.12	0.05	0.11	0.27
[MET, FGFR1, FN1]	0 (0.0%)	0.07	0.16	0.05	0.27
[MET, PIK3C2G, ITGB3]	0 (0.0%)	0.09	0.06	0.13	0.27
[EPHA7, TEK, ITGB3]	0 (0.0%)	0.08	0.05	0.14	0.27
[CYP27B1, PRAME, ITPR3]	0 (0.0%)	0.06	0.05	0.16	0.27
[MET, BCR, PRAME]	0 (0.0%)	0.07	0.06	0.14	0.27
[CDKN2A, BCR, TEK]	0 (0.0%)	0.09	0.05	0.13	0.27
[FGFR1, PIK3C2A, ITPR3]	0 (0.0%)	0.07	0.07	0.13	0.27
[PIK3C2A, FGFR3, BCR]	0 (0.0%)	0.07	0.06	0.14	0.27
[PIK3CG, ITPR3, ITGB3]	0 (0.0%)	0.08	0.04	0.14	0.27
[MET, FGFR1, DOCK1]	1 (0.79%)	0.07	0.15	0.05	0.26
[TEK, ITPR3, ITGB3]	0 (0.0%)	0.09	0.05	0.13	0.26
[FGFR1, CYP27B1, ITPR3]	0 (0.0%)	0.06	0.04	0.16	0.26
[PIK3CG, MET, PIK3C2A]	0 (0.0%)	0.09	0.06	0.11	0.26
[CYP27B1, FGFR3, ITPR3]	0 (0.0%)	0.06	0.04	0.16	0.26
[FGFR1, PIK3C2A, BCR]	0 (0.0%)	0.07	0.05	0.14	0.26
[PDGFRA, PIK3C2A, BCR]	0 (0.0%)	0.07	0.05	0.14	0.26
[MSH6, BRCA2, PRKDC]	0 (0.0%)	0.08	0.05	0.13	0.26
[FGFR1, ITPR3, ITGB3]	0 (0.0%)	0.07	0.08	0.11	0.26
[CDKN2A, TEK, ITGB3]	0 (0.0%)	0.10	0.05	0.11	0.26
[ITPR3, FGFR3, ITGB3]	0 (0.0%)	0.07	0.07	0.11	0.26
[FGFR1, BCR, PRAME]	0 (0.0%)	0.06	0.06	0.14	0.26
[BCR, PRAME, CYP27B1]	0 (0.0%)	0.06	0.06	0.14	0.26
[CDKN2A, TEK, EPHA7]	0 (0.0%)	0.09	0.04	0.13	0.26
[PDGFRA, BCR, PRAME]	0 (0.0%)	0.06	0.05	0.14	0.26
[BCR, FGFR3, PRAME]	0 (0.0%)	0.06	0.05	0.14	0.26
[ERBB2, CDKN2A, FN1]	0 (0.0%)	0.10	0.04	0.11	0.25
[CYP27B1, ITPR3, ITGB3]	0 (0.0%)	0.07	0.04	0.14	0.25
[BCR, TEK, EPHA7]	0 (0.0%)	0.07	0.05	0.13	0.25
[CDKN2A, BRCA2, PRKDC]	0 (0.0%)	0.09	0.05	0.11	0.25
[MET, PIK3C2A, BCR]	0 (0.0%)	0.08	0.06	0.11	0.25
[PDGFRA, PIK3C2A, ITPR3]	0 (0.0%)	0.07	0.05	0.13	0.25
[CDKN2A, PIK3C2A, FGFR3]	0 (0.0%)	0.09	0.05	0.11	0.25
[FGFR1, BCR, ITPR3]	0 (0.0%)	0.06	0.05	0.13	0.24
[FGFR1, CDKN2A, PIK3C2A]	0 (0.0%)	0.09	0.04	0.11	0.24
[FGFR1, BCR, ITGB3]	0 (0.0%)	0.06	0.08	0.10	0.24
[BCR, PIK3C2G, ITGB3]	0 (0.0%)	0.08	0.03	0.13	0.24
[BCR, FGFR3, ITPR3]	0 (0.0%)	0.06	0.05	0.13	0.24
[BCR, FGFR3, ITGB3]	0 (0.0%)	0.06	0.08	0.10	0.24
[FGFR1, CDKN2A, BCR]	0 (0.0%)	0.08	0.05	0.11	0.24
[BCR, PRAME, ITGB3]	0 (0.0%)	0.06	0.04	0.13	0.24
[CDKN2A, BCR, FGFR3]	0 (0.0%)	0.08	0.05	0.11	0.24
[MET, PIK3C2A, EPHA7]	0 (0.0%)	0.08	0.05	0.11	0.23
[PIK3C2A, FGFR3, ROR2]	0 (0.0%)	0.07	0.05	0.11	0.23
[MET, BCR, EPHA7]	0 (0.0%)	0.07	0.05	0.11	0.23
[MET, BCR, ITGB3]	0 (0.0%)	0.07	0.09	0.06	0.23
[PIK3CG, BCR, FN1]	0 (0.0%)	0.07	0.04	0.11	0.22
[PDGFRA, PIK3C2A, ROR2]	0 (0.0%)	0.07	0.04	0.11	0.22
[FGFR1, PIK3C2A, ROR2]	0 (0.0%)	0.07	0.04	0.11	0.22
[CDKN2A, FGFR1, ITPR3]	0 (0.0%)	0.08	0.04	0.10	0.22
[PIK3CG, MET, FN1]	1 (0.79%)	0.08	0.06	0.08	0.22
[CDKN2A, FGFR3, ITPR3]	0 (0.0%)	0.08	0.04	0.10	0.22
[BCR, ITPR3, ITGB3]	1 (0.79%)	0.07	0.04	0.11	0.22
[FGFR1, BCR, FN1]	0 (0.0%)	0.06	0.05	0.11	0.22
[BCR, FN1, PRAME]	0 (0.0%)	0.06	0.05	0.11	0.22
[PDGFRA, BCR, FN1]	0 (0.0%)	0.06	0.05	0.11	0.21
[FGFR3, BCR, FN1]	0 (0.0%)	0.06	0.05	0.11	0.21
[CYP27B1, PIK3C2A, ITPR3]	0 (0.0%)	0.07	0.04	0.10	0.21
[PIK3CG, MET, DOCK1]	0 (0.0%)	0.08	0.05	0.08	0.21
[CDKN2A, PRKDC, MSH6]	1 (0.79%)	0.10	0.05	0.06	0.21
[MET, PIK3C2A, ROR2]	1 (0.79%)	0.08	0.05	0.08	0.21
[CDKN2A, FGFR1, ITGB3]	0 (0.0%)	0.08	0.06	0.06	0.20
[CDKN2A, FGFR3, ITGB3]	0 (0.0%)	0.08	0.05	0.06	0.20
[MET, PIK3C2A, ITPR3]	0 (0.0%)	0.08	0.05	0.06	0.20
[MET, EPHA7, ITGB3]	0 (0.0%)	0.07	0.06	0.06	0.20
[MET, BCR, DOCK1]	0 (0.0%)	0.07	0.05	0.08	0.20
[MET, BCR, FN1]	0 (0.0%)	0.07	0.08	0.05	0.19
[BCR, FN1, TNC]	1 (0.79%)	0.06	0.08	0.05	0.19
[MET, ITPR3, ITGB3]	0 (0.0%)	0.08	0.06	0.05	0.19
[PIK3C2A, ROR2, ITPR3]	0 (0.0%)	0.07	0.05	0.06	0.18
[MET, DOCK1, EPHA7]	0 (0.0%)	0.07	0.04	0.08	0.18
[MET, PIK3C2A, FN1]	1 (0.79%)	0.08	0.05	0.05	0.18
[MET, FN1, TNC]	1 (0.79%)	0.07	0.09	0.02	0.18
[MET, PIK3C2A, DOCK1]	1 (0.79%)	0.08	0.05	0.05	0.17
[MET, DOCK1, ITGB3]	2 (1.59%)	0.07	0.06	0.03	0.16
[MET, FN1, EPHA7]	0 (0.0%)	0.07	0.04	0.05	0.16
[MET, DOCK1, FN1]	1 (0.79%)	0.07	0.04	0.02	0.13
